|
|
·|û¡G¹Ç§AÅó±ø±ø10135894 µoªí®É¶¡:2015/4/2 ¤W¤È 09:36:27
|
¯E¹©°O¡G 1¡n¯E¹©2015¦~3¤ë¥¿¦¡±q¿³ÂdÂà¤WÂd,«o±q400¤¸¶^¨ì250¤¸ 2¡nÀHµÛ¸Ñª¼®É¶¡±µªñ,¥«³õ¤W°ª«×ªºÃöª`»P°l±·,¿v©³Ãk¤É¨ì750¤¸ªº¤Ñ»ù 3¡n2016/2/21¸Ñª¼«á, ¥Ñ©ó¸Ñª¼¥¼¹F¹w¥ý³]©wªº¥Ø¼Ð, ¦A¥[¤W¦W¼L¥ß©e´CÅé½Ñ¦h¥H³_¶Ç³_,¥H°¾·§¥þ, ¥B¥¼¸gÃҹꪺ«ü±± ÁöµM¤½¥q»¡¯à°÷²£¥Í§ÜÅ骺±Ú¸s´N¯à°÷²£¥ÍÁ{§É¤WªºÀø®Ä,©ó¬O¦³©Ò¿×ªº"¤@ӸѪ¼,¨âºØ¸ÑŪ,¦U¦Ûªíz" ¤@¸ô¤U¶^¨ì350¤¸¥ª¥k 4¡n¦ý¦b2016/3/31²×©óªï¨ÓÀò±oASCO Oral presentationªº®¶¾Ä®ø®§,4¤ë1¤é·M¤H¸`·í¤Ñ,ªï¨Ó¤F¤[¹Hªº¤@¸ôº¦°±ªO 5¡n6¤ëªìªºASCO, ÁÞ¤k§Y±N´¦¶}¦oªº¯«¯µ±¯½ ¨Ì¾Ú²Î¤@§ëÅU±i¥ß¸s¤ÀªR®v¬ã¨s¡G https://www.google.com.tw/url?sa=t&rct=j&q=&esrc=s&source=web&cd=2&cad=rja&uact=8&ved=0ahUKEwins9egnPzLAhVikIMKHcc1DN8QFgggMAE&url=http%3A%2F%2Fpcmc.uni-psg.com%2Fvip%2F20160226-01.pdf&usg=AFQjCNHCCWDKl493HzcquFVIcJoolRPgnQ »PµL±¡¤jªº¤ÀªR¡G http://tsjh301.blogspot.tw/2014/08/obipharma.html ¥»µÛªø´Á§ë¸ê, °l®Ú¨s©³ªººë¯«¨Ó±´¯Á¯E¹©ªº§ë¸ê»ùÈ, ¤£¦]µu´ÁªÑ»ùªi°Ê°_¥ñ¦Ó¼vÅT¹ï "¥þ²y²Ä¤@ÁûFirst in class, Best in classªº§ÜÀùÁÞ¤À¤l¥þ·sÃĪ«"§ë¸êªº¼ö±¡ ¨ÃÅé²{¤½¥qÄ@´º: "³Ð³y¥xÆW¥Í§Þ«~µP,¦¨¬°Àù¯gÀøªkªº¥þ²y»â¯èªÌ" "2025¦~¦¨¬°¥xÆW¥Í§Þ²Ä¤@«~µP, 2035¦~¦¨¬°¥þ²yÀù¯gªvÀø»â¾É¤½¥q" Åwªï¤À¨É¥ô¦ó¹ï¯E¹©Ä@´º»P»ùȵû¦ôªº¬Ýªk»P°ª¨£~~ |
|
·|û¡G«ù¤[ªº¯E§J10140191 µoªí®É¶¡:2015/5/13 ¤W¤È 10:17:42²Ä 300 ½g¦^À³
|
®Ú¾ÚÄw½Xk½u³nÅé ¼í®õ«ùÄò¨C¤Ñ¦b¨âÓ¤áÀY¦Y³f50±i ¥xªF¤Úµá¯S¤ñ¸û¤Ö¬ù10±i ¤]¤w¸g¦Y¨ì230±i |
|
|
·|û¡GFaith10138335 µoªí®É¶¡:2015/5/13 ¤W¤È 10:09:24²Ä 299 ½g¦^À³
|
¦h¦h¤j ¤p§ÌÓ¤H»{¬°«Ü¦³¥i¯à ¦Ó¥B¥H¼í®õ¥þªº¶Rªk¨Ó¬Ý 910±i,ªá¤F¤@Ó¦h¤ëºCºC¶R,¤p§Ì¹ê¦b¤Ó¨ØªA¥L̪º@¤ß¤F,«¢«¢«¢ ¥i¥HÅ㨣,³q±`¦³¹³³o¼Ëªº¥D¤O¦b¦Y³f®É,ªÑ»ù¤£¤Ó·|°Ê «Ý¤@©wªº®É¤é¨ì¤F,ªÑ»ù¦ÛµM·|¦^¨ìÀ³¦³ªº»ù¦ì §Ṳ́]n§ó¨ã@¤ß ¯E¤ÍÌ,¥H¤U¬O¤p§Ìªº²q´ú,¤j®a¬Ý¬Ý´N¦n,ªÑªF·|®É¦A¨Ó¦LÃÒ 1.¨ì6¤ë3¤é¶}ªÑªF·|«e,¤¤ëªº´_µo¤H¼Æ±µªñ¦ý¤£·|¶W¹L·íªì³]©w»Ý´Á¤¤¤ÀªR¤§¤H¼Æ(³oÓ¤H¼Æ¤j®a¤ß¸Ìª¾¹D´N¦n) 2.¤°»ò®ÉÔ¥i¹F¦w¥þ¸Ñª¼¤H¼Æ,³Ì¤Ö³Ì¤Ö³£n¶W¹L349¤Hªº¤@¥b 3.¥H³oºØª¬ªp,«ÜÃø¹F¦¨«ç»ò¿ì?±N¥Ø¼Ð×¥¿¦¨100%©Î200% ¥H¤W¬O¤p²Äªº²q´ú,¦ý¤p§Ì±`²q¿ù,¤j®a°Ñ¦Ò´N¦n~~ |
|
|
·|û¡G¦h¦h10137435 µoªí®É¶¡:2015/5/12 ¤W¤È 10:05:01²Ä 298 ½g¦^À³
|
¥h¦~¼í®õ¥þ ¼í®õ·s ¦³³B¤ÀX¸ÎªÑ²¼ ¼í®õ¥þ¬ù¦¬¦^3»õ ³o¦¸¶R¯E¹© ¤]¬O3»õ¥ª¥k ¤£ª¾¼í®õ·s¬O§_·|¸ò¶i! |
|
|
·|û¡G¦n¤ßªº¯Q¾~10137878 µoªí®É¶¡:2015/5/12 ¤W¤È 09:33:59²Ä 297 ½g¦^À³
|
³Ì¤j¤á¥Îªº¬O§ë¸ê¤Hªº¿ú ªL¤j¤á¥Îªº¬O¦Û¤vªº¿ú þ¤@Ãä¤ñ¸û·|¶Kªñ²{¹ê? |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2015/5/11 ¤U¤È 11:43:58²Ä 296 ½g¦^À³
|
Cliff¤j 1¦P·N§A©Ò¨¥:¸Ñª¼«áªº¼Æ¾Ú±N·|±a°ÊStorm of Globo H¡AÅý¬ã¨stumor antigen of Globo H series¦¨¬°Åã¾Ç,Ó¤H»{¬°·|¦¨¬°Åã¾Çªºì¦]¥Î¥Õ¸Ü¨Ó»¡´N¬O¨ÅÀùOBI822ªº§ÜÀù¾÷¨î¦h¤¸«D¨ä¥L¤w¤W¥«©Î¬ãµo¤¤ªº¨ÅÀùÃįà±æ¨ä¶µI,§AªºÀuÂI§Ú³£¦³,§ÚªºÀuÂI§A¤£¥þ¦³ ,¨ÅÀùOBI822±N¦¨¬°Àù¯g§K¬ÌÀøªkªº¥ý¹£±oÂIªÌ 2 Globo H¹ê±a¦³Ãþ¦üPD-1ªº¤Ï«b¨®¾÷¨î. ÁöµMÃþ¦üPD-1ªº¤Ï«b¨®¾÷¨î,Ó¤H»{¬°¨ÅÀùOBI822¨S¦³¤Ï«b¨®¾÷¨î±a¨Óªº§K¬Ì¤OµL«×ªº§ðÀ»¯f±w±a¨Óªº¦p¥Õ´³¯gµ¥°Æ§@¥Î,³oºØ§C°Æ§@¥Î¤£®e©¿µø¨ä©Ò±aµ¹¯f±w·¥¨Îªº¦n³B |
|
|
·|û¡G±Û«a10139522 µoªí®É¶¡:2015/5/11 ¤U¤È 09:53:44²Ä 295 ½g¦^À³
|
¬Oªº¡Afaith¤j¡AÄw½X¬Û¹ïéw¦h¤F¡A±µ¤U¨Ó¥iª`·NªÑªF·|±i¸³±N´¦¥Ü¤°»ò·s°T®§¡A¥H¤Î§Ú¤@ª½¦bºò¨nªºªk¤H¦ó®É¦³³sÄò©Êªº¶i³õ¡C |
|
|
·|û¡GFaith10138335 µoªí®É¶¡:2015/5/11 ¤U¤È 09:32:25²Ä 294 ½g¦^À³
|
±Û«a¤j ¤p§Ì¦P·N±zªº»¡ªk¡A¨S¿ù¡A§ÚÌ¥±`¤ß¬Ý«Ý§Y¥i ¦ý¡A¦A¥J²Ó«ä¦Ò¡A¼í®õ¥þªá¤F¤@Ó¦h¤ëºCºC¶R¡B¦A¥[¤W¤µ¤Ñªº¹dÃB¥æ©ö °_½X¡A¥Ø«e³o¨ÇÄw½X¬O¬Û¹ïéwªº ¤]ºâ¦n¨Æ°Õ |
|
|
·|û¡G±Û«a10139522 µoªí®É¶¡:2015/5/11 ¤U¤È 09:03:58²Ä 293 ½g¦^À³
|
¤@¯ë¹dÃB¥æ©ö¹ïªÑ²¼«á¥«³£¦³¥¿±ªº¼vÅT¡A¦]¬°¥Î¹dÃB¥æ©ö¨Ó¶RªÑ²¼ªº§ë¸ê¤H¡A¦h¥b¬O¬Ý¤W¤½¥q¥¼¨ÓÀò§Q«e´º¨Î¡A¥t¥~¡A³z¹L¹dÃB¥æ©ö¶R¶i«á³q±`¤£·|°¨¤W½æ¡A·|µ¥¨ì¤U¤@Óªi¬q¤~¶}©l½æªÑ¡C ¤£¹L¡A¥Ñ©ó¬OÃÒ©Òµ|´cªkªº«á¿ò¯g¼vÅT¡A©Ò¥H·¥¥i¯à¤S¬O¤j¤áÂà´«¦¨¤WÂd¦¨¥»ªºÁ×µ|°Ê§@¡A¦]¦¹¼È®É©y¥H¤¤©ÊºA«×¬Ý«Ý¡C |
|
|
·|û¡GFaith10138335 µoªí®É¶¡:2015/5/11 ¤U¤È 04:48:10²Ä 292 ½g¦^À³
|
ªÑ¥«n»D¡G¶g¤@(11¤é)ªÑ²¼¥«³õ¹dÃB¥æ©ö·§ªp 2015/05/11 16:00 °]°T§Ö³ø ½s¿è³¡ ¡i°]°T§Ö³ø¡þ½s¿è³¡¡j¶g¤@(11¤é)¹dÃB¥æ©ö·§ªp¦p¤U¡G ªÑ¡@²¼¡@ ¥N¸¹¡@ ¼Æ¶q(±i)¡@ »ù®æ(¤¸) ¼s¡@¹F¡@ 2382¡@¡@1,000¡@¡@ ¡@77.68 ¥üÂת÷¡@ 2886¡@¡@¡@500¡@¡@ ¡@26.80 Áp¡@µú¡@ 3034¡@¡@¡@105¡@¡@¡@153.71 øÊ¡@¬ì¡@ 3663¡@¡@¡@500¡@¡@¡@ 25.00 ¯E¡@¹©¡@ 4174¡@¡@¡@302¡@¡@¡@333.00 ¯E¡@¹©¡@ 4174¡@¡@¡@164¡@¡@¡@330.00 ¯E¡@¹©¡@ 4174¡@¡@¡@260¡@¡@¡@329.00 ¥@¡@¬É¡@ 5347¡@¡@¡@500¡@¡@¡@ 45.92 ¥@¡@¬É¡@ 5347¡@¡@¡@500¡@¡@¡@ 45.93 ¬ü§Q¹F¡@ 9914¡@¡@¡@255¡@¡@¡@228.44 ¸ê®Æ¨Ó·½¡GÃÒ¥æ©ÒÆ[´ú¯¸ »sªí¤H¡G¾G¯À®Z TOP |
|
|
·|û¡G¯ä¦Ñ¹«10139175 µoªí®É¶¡:2015/5/11 ¤U¤È 04:24:24²Ä 291 ½g¦^À³
|
¤§«e¦Ñ¬O¾a¥_¤j¤á¦ª¾¹DXX§QªÅ©Ò¥H½æªÑ²¼ ¥i¬O¤µ¤Ñ³Ì¤j¤áÁÙ¬O¥[½X50±i ¦í¤¯·R¸ôªº¤]¥[½X40¦h±i ¦í°ª¶¯ªº¤]......«ç»ò¤£§ï¤f³Ì¤j¤á¦ª¾¹D¡H ¥i¨£³o¨ÇµL²á¤H¤h¯Âºé¶¢¶¢¨S¨Æ·F³ßÅw¥´¼L¯¥ ³Ì¦n¯E¹©¯à©ñªÅÅý³o¨Ç·R¾a¥_ªº¥h©M³Ì¤j¤áµ¥¤H¹ï§@ |
|
|
·|û¡G¹Ç§AÅó±ø±ø10135894 µoªí®É¶¡:2015/5/11 ¤U¤È 02:08:55²Ä 290 ½g¦^À³
|
¯Q¾~Á`¦Ñ¬O³ßÅw¦b¨ºùØ¥s§r¥s¡A¤£ºÞ¬O"¶Ô¶Ô¥s"ÁÙ¬O"ÃiÃi¥s" ¦pªG»¡¬O¦]¬°¦³"¥_·¥¬P"¨ÓÅͧ½¨¥¤§¦³ª«ª©¤W¤j¤j³£·|¸ò§A»¡ÁÂÁÂ, ½Ð¨¥¤§¦³ª«¦n¶Ü ~~ ¤£¹L¥_·¥¬P¤]¬On¥ý¨Ó¹ï¥I¨xÀù¡A¨ÅÀù¤]¥¼¦bÀu¥ý¶¶¦ì t±ªº¶H¼x http://zh.wikipedia.org/wiki/%E4%B9%8C%E9%B8%A6 ¾¨ºÞ¦³¨Ç¤å¤Æ»{¬°¯Q¾~¬O¦N²»ª«¡A¦ý¬O¦b³¡¥÷¤å¤Æ¡]¨Ò¦p¡G¦L²Ä¦w¤å¤Æ¡^»{¬°¬O¤£²»¤§¥ü¡A¯Q¾~¥i¯à¥Nªí¤@ºØ¤O¶qªº¶H¼x¡AµM¦Ó¦pªG¬O¥Nªí¤O¶qªº¸Ü³q±`·|¬O«üt±ªº¤O¶q¡C http://udn.com/news/story/7485/847847-%E5%8C%97%E6%A5%B5%E6%98%9F%E8%BF%94%E9%84%89-%E6%8A%97%E7%99%8C%E8%97%A5%E5%B0%87%E5%95%8F%E4%B8%96 ¥_·¥¬Pªð¶m §ÜÀùÃıN°Ý¥@ 2015-04-20 04:01:45 ¸gÀÙ¤é³ø °OªÌ¶À¤å©_¡þ¥x¥_³ø¾É ¥_·¥¬PÃÄ·~¦^¨Ó¤F¡A¸³¨Æªø§d§B¤å±N«Å¥¬¡A¤½¥q¹w³Æ³W¹º¦^¥x¤WÂd¡A®µ§ÜÀù·sÃħ޳N¥¥x¡uADI-PEG 20¡v¡]¥H¤U²ºÙADI¡^¤w¦b¥þ²y§¹¦¨11ÓÁ{§É¸ÕÅç¡AÁÙ¦³11Ó¥¿¦b¶i¦æ¤¤ªºÁ{§É¸ÕÅç¡A°w¹ï¤Q¦h¶µÀù¯g¾AÀ³¯g¦P®É¶i¦æ´ú¸ÕªºÀu¶Õ¡A·~¬É»{¬°¡A¸Ó²£«~¦³¾÷·|·m¦b¯E¹©¤§«e¡A¦¨¬°µØ¤H²Ä¤@Ó°ê»Ú©Êªº³J¥Õ½è·sÃÄ¡C ADI±N§¹¦¨¥þ²y¦h°ê¦h¤¤¤ßÁ{§É¤T´Á¨xÀù¸ÕÅç¡A¦b¬ü°êª¾¦WÀù¯g¤¤¤ßMSKCC»â¾É¤U¡A¦b¬ü¡B¥x¡B^¡B¸q¡B¤¤¡B Áú¦U°ê¾ú®É¤T¦~¥b¦@¦¬¿ý636¦W¥½´Á¨xÀù¯f¤H¡A¨ä¤¤¥xÆW´N¦³194¤H¡A¤½¥q¹w´Á¦b¤µ¦~©³§¹¦¨¼Æ¾Ú¤ÀªR¡A¦pªG¤@¤Á¶¶§Q¡A¥i±æ©ú¦~¤U¥b¦~¦b¬ü¡B¼Ú¡B¥x¨ú±oÃÄÃÒ¡C ¦Û2005¦~¥H¨Ó¡A©Ò¦³ADI°w¾¯³£¬O¥Ñ¥_·¥¬PÃÄ·~¦b¬ü°êªº¥_¥[¦{¤l¤½¥qDesigneRx Pharmaceuticals¥Í²£¡C¦´ÁªºÁ{§É¬ã¨sµÛ«©ó³æ¤@ªvÀø¡A¥]¬A¨xÀù¡B¶Â¦â¯À¥Ö½§Àù¥H¤ÎªÍ¶¡¥ÖÀùªºÁ{§É¤G´Á³£¦³¨}¦nÀø®Ä¡C¦b¥xÆW§ó¦³¥H®¦·OÀøªk¤è¦¡¡]compassionate use¡^¥Ó½Ð¯S³\¶i¤f¦Ó¦h¦¸¦¨¥\ªv¡¨xÀù¥½´Á±wªÌªº¬ö¿ý¡C¥Ø«e±N§¹¦¨ªº¥þ²y¨xÀù²Ä¤T´ÁÁ{§É¸ÕÅç¡A¤]¬O¥H³æ¤@¥ÎÃÄ¡B²Ä¤G½uªvÀø¼Ò¦¡¡C ³Ìªñ´X¦~¥_·¥¬PÃÄ·~»P¬ü¡B^¡B¥x¦U¦a20¦hÓÀù¯g¤¤¤ß¤Î¤j¾Ç¦X§@¡A±´°Q¥HÁp¦X¥ÎÃĤ覡±NADI»P¤@ºØ©Î¦hºØ¤ÆÀøÃĪ«²Õ¦X°w¹ï¦UºØÀù¯g¶i¦æªvÀø¡Aµo²{Áp¦X¥ÎÃĹï¦hºØÀù¯g¥i¹F¨ì§ó¥[ÅãµÛªºÀø®Ä¡C ¥Ø«e¥¿¶i¦æ¤¤ªºÁp¦X¥ÎÃÄÁ{§É¸ÕÅç¡A¥]¬A¦b¬ü°ê§ÜÀù¤¤¤ßMD Andersonªº¶Â¦â¯ÀÀù¡B¤l®cÀVÀù¡B¨xÀù¡BÁxºÞÀù¡B¨ÅÀù¡A¦bMSKCCªº¯ØŦÀù¡B¨xÀù¡A¦b¥[¦{¤j¾ÇªºÄáÅ@¸¢Àù¤Î«D¤p²ÓMªÍÀù¡A¥H¤Î¦b^°êÛ´°BartsÂå°|»P¼C¾ôªºªÍ¶¡¥ÖÀù¡B«D¤p²ÓMªÍÀù¡B¤Î¸£Àù¡C¤½¥q§ó³W¹º¦b¤µ¦~²Ä3©u®i¶}²Ä¤GÓ¥þ²y¦h°ê¦h¤¤¤ßªº²Ä¤T´Á¨xÀùÁ{§É¸ÕÅç¡A¸Ó¸ÕÅç±N¥HADI·f°t¶¶¹`¡]cisplatin¡^°µ¤@½uªvÀø¡Aª½±µ©M¥Ø«e°ß¤@¤W¥«ªº¨xÀùÃĹp¨F¥Ë¡]Nexavar¡^°µ¹ï¤ñ¡C ¥_·¥¬P¶°¹ÎºX¤U¾Ö¦³¥_·¥¬PÃÄ·~¥H¤ÎÃö«Y¥ø·~·çµØÃÄ·~¡A¨âªÌ³£¬O·sÃĶ}µo¤½¥q¡A¦ý«eªÌ»EµJ§ÜÀù¥ÎÃĶ}µo¡A«áªÌ«h¦P®É¨ã³Æ³J¥Õ½èÃĶq²£¯à¤O¡C·çµØ°£«ù¦³¥_¥[DesigneRx¼t¥~¡A¤]¦b¤j³°¦¨³£°ª·s¦è°Ï«Ø³]¥¼¨Ó¥i¥H¨ÑÀ³¥þ²y¥«³õ»Ý¨Dªº·s¼t¡C·íªì§d§B¤å¦]¦U¶µ¦]¯ÀÅfµM±Ë¥x´N³°³]¼t¨¯W³Æ¹Á¡A¥L³zÅS¡A¥¼¨Ó¤´§Æ±æ§â¨ä¥L¾÷·|¯dµ¹¥xÆW¡A´«¨¥¤§¡A¦^¥x¤W¥«Âd¶È¬O§Ç¦±¡C http://www.cpmda.org.tw/news_show_n1.php?news_id=1276 ¥_·¥¬P ©é¦~©³¦b¬ü¤W¥« ¤º®e Polaris Group¡]¥_·¥¬P¶°¹Î¡^¬ãµoªvÀø¨xÀù¥ÎÃÄADI-PEG 20±N¶i¤JFDA¤T´ÁÁ{§É¹êÅç¤U¡A±N¼³Ó°lÀ»¡A·m¦b¬ü°ê¤W¥«±¾µP¥Í§ÞªÑ¡A¨Ã¥ÑÂà§ë¸ê¤½¥q·çµØ·sÃĦb¥xÆW¿³«Ø³J¥Õ½èÃļt¡A¥d¦ì¥«³õ°Ó¾÷¡C ¥_·¥¬P¶°¹Î¸³¨Æªø§d§B¤åªí¥Ü¡A¥Ø«e¤w¦³¤£¤Ö°ê»ÚÃļt¶}©l¬¢½Í±ÂÅv¡A¦ý¬°¤FÅý¥¼¨ÓµØ¤H¯à¨É¨ü¸û«K©yªºÃÄ»ù¡A¤½¥qÁÙ¬O·|«O¦³¨â©¤ªº¾P°âÅv¡A¨Ã³z¹L·çµØ¾P°â¡A¦]¦¹¡A·çµØ·sÃÄ¥H«á±N±Mª`©ó¾P°â©M¥Í²£¡A¹wp¥i®i²{¤£¿ùªº¦¨ªø¤O¹D¡C §d§B¤åªí¥Ü¡A¥Ø«eADI-PEG 20°£¤F¶i¦æ¨xÀù¤T´ÁÁ{§É¥~¡A¤]±N¾É¤J¦åÀù¡B¯ØŦÀùªº¤G´ÁÁ{§É¡A¦Ó²O¤ÚÀù¡B¦×Àù¡B¤p²ÓMªÍÀù¡BÄáÅ@¸¢Àù¤]¤À§O¦b¬ü°ê¡B¼w°ê¡B^°ê¡B¥xÆWµ¥¶i¦æ¤G´Á©M¤@´ÁÁ{§É¡C Polaris Group¦¨¥ß©ó2006¦~¡A¥Ø«e¶°¸ê7,500¸U¬ü¤¸¡A¬O±M¨Æ·sÃĶ}µoªº¸ó°ê¤½¥q¡AÁ`³¡³]¥ß©ó¬ü¦è¥[¦{¡A¾Ö¦³¦h¶µ³J¥Õ½èÃĪ«¥þ²y±M§QÅv¡A¨Ã©ó2008¦~©³¥H´«ªÑ¤è¦¡¡A¨ÖÁÊ¥xÆW·çµØ·sÃĬãµo¤½¥q¡C Polaris Group¥Dn§ë¸ê¤H¥]¬A·sªF¶§¶°¹Î¡]«ùªÑ©~«a¡A¬ù37¢H¡^¡B¥üÂ׻Ȧæ¡B¤¤¥[³Ð§ë¡]®}¥ß¼w§ë¸ê¦¨¥ß¡^¡B¼ÚµØ³Ð§ë¡]°ª¨|¤¯§ë¸ê¦¨¥ß¡^¡B¥xÆW¤u»Èªi¤h¹y³Ð§ë¡B©ø©Ó¦³¤½¥q¡B«H±d§ë¸ê¤Î¤¤¤p¥ø·~³B¡A¸êª÷90¢H¥H¤W¨Ó¦Û¥xÆW¡C ¥X³B ¤u°Ó®É³ø/°OªÌ§ù¿·»T |
|
|
·|û¡G¦n¤ßªº¯Q¾~10137878 µoªí®É¶¡:2015/5/11 ¤U¤È 02:04:50²Ä 289 ½g¦^À³
|
¨ß¤l©ú©ú°µ¤F«Ü¦h¤H¨§ðÀ» «Ü¦h¤H³£³Q¥L½|¹L §A¤]Âk¥L¬°µ½¤H ¦]¬°¥LÁ¿ªº¸Ü³£¬O§A·RÅ¥ªº? ¤Ó°¾¤ß¤F |
|
|
·|û¡GOOXX10022393 µoªí®É¶¡:2015/5/11 ¤U¤È 01:48:00²Ä 288 ½g¦^À³
|
¬Ý¨Ó¯Q¾~¬O¦Û¤v¨S¯à¤O ¤S¾L¨ý«°Ú¡I~~ |
|
|
·|û¡G¦n¤ßªº¯Q¾~10137878 µoªí®É¶¡:2015/5/11 ¤U¤È 01:42:50²Ä 287 ½g¦^À³
|
n¾Ç§Ú¥i¥H §Ú«Ü¤j¤èªº ¤£n§â§Ú·í°¸¹³´N¦n ¹Ã¹³ok °¸¹³±R«ô¬O«Ü®e©öÅý¤H°g¥¢ªº |
|
|
·|û¡GJm042310140224 µoªí®É¶¡:2015/5/11 ¤U¤È 01:34:43²Ä 286 ½g¦^À³
|
xxªº¯Q¾~ ¤£n¦A¦Ã¬V¦¹ª©¤F¡A¥H«á¤£¦A¦^À³ ½Ö¬O½Öªº¦n¥ë¦ñ¡A¤£n¶Ã¦©¤H´U¤l¤ÎÀH«K¤H¨§ðÀ»¦p¶BÄF¶°¹Îµ¥ n±j½Õªº¬O¡A¬Ý¦h¬ÝªÅ³£À³¦³¨ä¥ß½×°ò¦ ¤£¬OÀH«K³Û³Û¡A©ÎµLªº©ñ¥Ú¡A©Î¾ÌªÅ®º³y´N¤W±o¤FÂi± ¦h¾Ç¾Ç¦¹ª©¥O¤H·q¥õªºcliff¤j¡B¤p©_¤j¡B¹«¤j¡Bfaith¤j¡B±ø¤j¡B¥xÁÞ¤j¡B²q·Q¤j¡Brabbit¤j¡A¡B¡B¡]±ÚÁc¤£¤Î³Æ¸ü¡^µ¥ªº½×z¯à¤O ¤ÎµL¨p¤À¨Éªºµ½¤ß |
|
|
·|û¡G¤p±i10135877 µoªí®É¶¡:2015/5/11 ¤U¤È 01:10:58²Ä 285 ½g¦^À³
|
¹Ã¹³?¯u¬O¤Ó"®üÃä"¤F |
|
|
·|û¡G¦n¤ßªº¯Q¾~10137878 µoªí®É¶¡:2015/5/11 ¤U¤È 01:03:31²Ä 284 ½g¦^À³
|
§A¬°¤°»òn¾Ç§Ú»¡¸Ü §Ú¤£·Q·í°¸¹³ |
|
|
·|û¡G¤p±i10135877 µoªí®É¶¡:2015/5/11 ¤U¤È 01:01:21²Ä 283 ½g¦^À³
|
§Ú»¡¬O¬O¶Â¾~¤£¬O¯Q¾~ §O¹ï¸¹¤J®y°Ú,¦Ó¥B¬O"¦pªG",´N¹³§AÁ¿§O¤H¬O¶BÄF¶°¹Î¤@¼Ë,§O°µ...³Û®».... |
|
|
·|û¡G¦n¤ßªº¯Q¾~10137878 µoªí®É¶¡:2015/5/11 ¤U¤È 12:52:22²Ä 282 ½g¦^À³
|
jm0423±Ð±Ð§Aªº¦n¹Ù¦ñ§a »P¥L¬Ýªk¤£¦P´Nn¤H®a±oÀù n¤H®a¦º ³oÓª©¯uªº¬ÝºÉ¤H¥Í¦ÊºA ¦³ªº¤H¯uªº¬°¤FÁÈ¿ú¤°»ò¸Ü³£Á¿ªº¥X¨Ó |
|
|
·|û¡GFaith10138335 µoªí®É¶¡:2015/5/11 ¤W¤È 11:38:40²Ä 281 ½g¦^À³
|
¤µ¦8ÂI¦hÀ³¸Ó¦³¤@«h°T®§ ¥i±¤¤p§Ì¿ù¹L¤F §Ú¥´¶}ª©±®É,µo²{°±¯d¦b°e³ø¤j5¤ë9¤é¤U¤È3ÂI¦hªº°T®§ ¬JµMª©¥D§R¤F,·Q¥²¦³ª©¥Dªº¦Ò¶q ´N~ÀH½t§a ¤U¦¸¨nª©n¨nºò¤@ÂI~«¢«¢«¢ |
|
|
·|û¡GYunyun10140355 µoªí®É¶¡:2015/5/11 ¤W¤È 11:36:42²Ä 280 ½g¦^À³
|
³o®ÉÔ½Ö¥Õ¥Ø ½ÖË·°? ¤¤¸Î ÃÄµØ Ä_ÄÖ±þ¦¨³o¼Ë ½Ö¼Ö¨£©O? ·íªì¤]¬O±q¤@¤G¤Q¤¸¤@¸ôº¦¤W¨Ó ÁÈ¿ú«Ü¶}¤ß ½ß¿ú«Ü¤ßµh¤H¤§±`±¡ °]´I«·s¤À°t ³£¦³¤@©wªºì¦] ¦U¦ì¦h¦h«O«. |
|
|
·|û¡G¤p±i10135877 µoªí®É¶¡:2015/5/11 ¤W¤È 11:36:03²Ä 279 ½g¦^À³
|
¦pªG¶Â¾~±o¤FÀù,¤d¸U¤£n¥Î¯E¹©ªºÃÄ,¸Ó«ç»ò¦º´N«ç»ò¦º |
|
|
·|û¡G¦n¤ßªº¯Q¾~10137878 µoªí®É¶¡:2015/5/11 ¤W¤È 11:31:16²Ä 278 ½g¦^À³
|
§Ú¥u¬O¥H¶BÄF¶°¹Î°µ¤ñ³ë ±zµwn§â¤H®a¹ï¸¹¤J®y ¸o¹L¸o¹L |
|
|
·|û¡Gjm042310140224 µoªí®É¶¡:2015/5/11 ¤W¤È 11:23:00²Ä 277 ½g¦^À³
|
¬ÝªÅ/¬Ý¦h¬O§Aªº¨Æ¡A¥¢©Î±o¥u¯àÂk½Ñ©ó¦Û¨ªºµLª¾¤£§V¤O©Î¦Û¨ªº§V¤OÆp¬ã¤Î°ª¤HªºµL¨p¤À¨É ¤£§V¤O¨V¨úª¾ÃÑ´x´¤¾÷·|¡A«o»¡§O¤Hªº§V¤O¡B¤¯¤ß¬O¶BÄF¯Å¹Î¡A³o¬O´c½èªº¡A¤£¬O¦n¤ßªº ¦³§Îªº¡A§A¥i¯à¦]¦ÓµLªkÀò±o³øÀv ¤Ï¦ÓµL§Îªº¡A§A³y¤F·~»Ù |
|
|
·|û¡G¤p±i10135877 µoªí®É¶¡:2015/5/11 ¤W¤È 11:18:41²Ä 276 ½g¦^À³
|
²{¦b¶^¦¨³o¼Ë½Ö´±¦A§ë¸ê·sÃĪѰÚ,²{¦b´±¶R¯E¹©ªº¬O©ê¥²¦º¨M¤ß§a ¦³½ÖÁÙ·|³g°ý°Ú? |
|
|
·|û¡G¤p©_10138298 µoªí®É¶¡:2015/5/11 ¤W¤È 11:06:47²Ä 275 ½g¦^À³
|
¦pªG¦³¥ø·~®aÄ@·N¤j¤OÃÙ§U¡A¦pªGÃQ¾É©Î§õ¾É»{¦P¦¹¤@µLÃöºØ±Ú¡BµLÃö°ê¬Éªº´¶¥@ÃD§÷ ¥xÆW±N¥i¥H¦³¤@³¡¥i¥H±À¤W°ê»Úªº¹q¼v°Ý¥@ ¥xÆWª©¡B¯u¹ê¬G¨Æ§ï½sªº¡u¾Ö·R©_ÂÝ¡v §ó¦h·P¤HªÍµÆ¡B¥iºq¥iª_ªº¬G¨Æ¤w¦b±wªÌ»P®a¤H¤§¶¡²£¥Í §ó¦h¥Í©Rªº©_Âݤw¸g¦b©Î§Y±N¦b±wªÌ»P®a¤H¤§¶¡®i¶} ¡y´X¦~«á³oÓª©ªº¦s¦b±N¦¨¬°¤j®a¯ù¾l¶º«áªº¸ÜÃD ¥H¤ÎÄU¥@ªºÃD§÷¡z ¹q¼vùتº¸õ±ç¤p¤¡¤£¤]±`±`¬O¼W¥[¹q¼v¥i¬Ý©Ê¤Î½ì¨ý©Êªº¤Hª«¡I |
|
|
·|û¡G¹Ç§AÅó±ø±ø10135894 µoªí®É¶¡:2015/5/11 ¤W¤È 11:02:44²Ä 274 ½g¦^À³
|
¯Q¾~¥S¡A½Ð¤Å"¿ù§â¶¾¨Ê·í°¨²D" ©Î³\80%¥Í§Þ·sÃĪѬO"µL°ò¤§¼u"¡A¦ý20%½T¬O"©M¤ó¿\¥É" ©Î³\¦³¨Ç¥Í§ÞªÑ¤w¸g¶^ªº»ó«CÁy¸~¡A¦ý¤£¬O©Ò¦³¥Í§ÞªÑ³£·|¦p¦¹ °O±oªÑ¤ý§»¹F¹q¡A2011¦~4¤ë1300¤¸¡A¤µ¤Ñ¶^°±111¤¸³Ð¾ú¥v·s§C¡A³Ñ¤U¤£¨ì¤Ñ»ù®Éªº¤Q¤À¤§¤@ ¤£¥Î¥Í§ÞªÑ¡A¹q¤lªÑ¤]³£¤ñ¤ñ¬Ò¬O¡A¯ù¾l¶º«á¸ÜÃD¦³«Ü¦h¡A¤£¥Î§ä¥Í§Þ¨Ó½Í ¿ù§â¶¾¨Ê·í°¨²D¨å¬G¡Ghttp://d9116903.blogspot.tw/2006/11/blog-post_29.html ¶¾»P°¨¡A®t¨âºJ¡A¨Ê»P²D¡A®t¤TºJ¡I±N¡u¶¾¨Ê¡v»~¬Ý¦¨¡u°¨²D¡v¡A¤£¬O¦Ñªá¡A´N¬OŪªº§Ö¤F¨Ç¡I¶¾°¨¤¬´À¡A¨Ê²D¥æ¿ù¡A¦pªG¥u¬O¾x¾x¯º¸Ü¡A¨ì¤]µL¶Ë¤j¶®¡A¹ê¦bµL¶·¤Ó¹L»{¯u¡I |
|
|
·|û¡G¦n¤ßªº¯Q¾~10137878 µoªí®É¶¡:2015/5/11 ¤W¤È 10:01:33²Ä 273 ½g¦^À³
|
´X¦~«á³oÓª©ªº¦s¦b±N¦¨¬°¤j®a¯ù¾l¶º«áªº¸ÜÃD ¥H¤ÎÄU¥@ªºÃD§÷ ³g°ý»P°g«H¦p¦ó¨Ï¤H°g¥¢? ¶BÄF¶°¹Î¬O«ç»òÅý¤H¤W¹_ªº? µª®×´N¦b§A§Ú¤ß¸Ì, ¦ý±¡¤£¦Û¸Tªº¸õ¤W¥h«r»çªº¤ñ¤ñ¬Ò¬O...... |
|
|
·|û¡G°e³øªº10135990 µoªí®É¶¡:2015/5/9 ¤U¤È 03:57:05²Ä 272 ½g¦^À³
|
¦A¶Ã²q¤@Ó.. ¤U©P¤@°_Ãöª`¤@¤U.¥Ø«e¦¨¤ÀªÑùØ¥u¦³¯«¶©¤@ÀɥͧުÑ. MSCI°õ¦æ«ü¼Æ©w´Á¼f®Ö»P½Õ¾ã¤§¤ë¥÷¬°¨C¦~ªº2¤ë¡B5¤ë¡B8¤ë¤Î11¤ë¡A¨äºô¶(http://www.msci.com/products/indices/size/index_review.html)¥Zµn¼f®Ö½Õ¾ãµ²ªG¤½§i¤Î¥Í®Ä¤é´Á¡A¥Ø«e¤wµo¥¬¤§½Õ¾ãµ²ªG¤½§i»P¥Í®Ä¤é´Á¤À§O¬°2015¦~²Ä1©u2¤ë11¤é¡B3¤ë2¤é¡F²Ä2©u5¤ë13¤é¡B6¤ë1¤é¡F²Ä3©u8¤ë13¤é¡B9¤ë1¤é¡F²Ä4©u11¤ë12¤é¡B12¤ë1¤é(¤é´Á¬Ò¬°¼Ú¬w¤¤³¡®É¶¡, UTC+1)¡C |
|
|
·|û¡GFaith10138335 µoªí®É¶¡:2015/5/9 ¤U¤È 01:54:52²Ä 271 ½g¦^À³
|
¥xÁÞ¤j¡Booxx¤j ±z̤@¦ì«ä¸ô²M´· £¸¦ì¦B³·Áo©ú «¢«¢«¢ |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2015/5/9 ¤U¤È 01:36:52²Ä 270 ½g¦^À³
|
OOXX ¤j ì¨Ó¦p¦¹, ¬Ý¨Ó¬O§Ú·P«_µo¿N¡AJ¨¥¶Ã»y |
|
|
·|û¡GOOXX10022393 µoªí®É¶¡:2015/5/9 ¤U¤È 01:24:01²Ä 269 ½g¦^À³
|
¥xÁÞ¤j¤j¡A¤È¦w Faith¤j¤jªº·N«ä¡AÀ³¸Ó¬O§â¹w¨¾©Ê¬I¥´¤]ºâ¶i¥h¤F§a¡C ¤pÁu¤]n¯¬ºÖ¥þ¤Ñ¤U¥À¿Ë ¥À¿Ë¸`§Ö¼Ö¡I |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2015/5/9 ¤U¤È 01:08:00²Ä 268 ½g¦^À³
|
Faith ¤j §A³Ìªñ¦³·P«_µo¿N¶Ü¡H ¥þ¤Ñ¤Uªº¥À¿Ë³£¯à¥Î¨ì¯E¹©ªºÃÄ? ¦³¨º»ò°ªªº¤ñ²v¶Ü? §Ú·QÀ³¸Ó¬Oµ§»~¡A¶}Óª±¯º¡H ¯E¹©ªº¨ÅÀùÃĤW¥«®É¶¡·|¶W¥X¤j®a·Q¹³¤Oªº·¥ ¯¬ºÖ¥þ¤Ñ¤U¥À¿Ë ¥À¿Ë¸`§Ö¼Ö |
|
|
·|û¡GFaith10138335 µoªí®É¶¡:2015/5/9 ¤U¤È 12:31:46²Ä 267 ½g¦^À³
|
Åó±ø±ø¤j ¤p§Ì¤]»{¦P±zªº¬Ýªk ¸Õ·Q¡A±i¸³©M¨äû¤u»{ªÑ½Ò§¹µ|¦¨¥»³£¨Ó¨ì340¤F ¼í®õ¶°¹Î¶R¦b332¥ª¥k¡A¥±`¤ß¬Ý«Ý´N¦n ¦Ü©óªÑ»ùn¶}©lº¦¡A¤p§Ì¨Ã¤£»{¬°£¸©w¦p¦¹ ³Ì«nªºÁÙ¬O°ò¥»± 5¤ë¡A³oÓ¤ë©Ò¦³¯f¤H¬Ò¤w¥Î§¹ÃÄ¡A¦@¾ú¸g9Ó¤ë¤F ¤p§Ì²`¤Á´Á¬ß¡A³Ì§Ö«á¦~¡A¥þ¤Ñ¤U¥À¿Ë³£¥i¥Î¨ì¯E¹©ªºÃÄ ¤£¦A¸g¾ú®£ÄßµhW®`©È |
|
|
·|û¡G¹Ç§AÅó±ø±ø10135894 µoªí®É¶¡:2015/5/9 ¤U¤È 12:04:24²Ä 266 ½g¦^À³
|
·PÁ¦U¦ì¤j¤j°lÂܤj¤áªº°Ê¦V¡A®ü¤j¤áÀ³¸Ó¬O¥X¥ú¤F¤Ï¦Ó¬O¦n¨Æ¡A³s¦P¥~³ò¤@¦P¤U¨®»¡BYE BYE§a~ ±q¼í®õ¥þ¤½§i3/31~5/8¶R¶i¡A¥i¥Hª¾¹D3/31¬O¯E¹©¬O§_n¶^¯}©Ó¾P»ù310¤¸ªº«n¤é¤l¡A ¼í®õ¥þ³oµ§§ë¸êÀ³¸Ó¬O¥ýÀ°¦£Å@½L¬°¥D¡A¤¨¦Ñ¤j¥»¨Ó´N±¡¸q¬Û®¼¯E¹©¬Æ¦h ¦Ü©ó¬O§_·|¶}©l¤Wº¦¡A¤p§Ì¥H¬°¨¥¤§¹L¦¡A¦]¬°Å@½Lªº¥Î·N¬O¤î¶^¡A¦Ó«Dª£ªÑ ·|¥Î¥§¡332ªº»ù®æ¶R¶i·íµM¬O»{¬°³oÓ»ù¦ì¨ã¦³§ë¸êªº°Ê¾÷ ¦]¬°¦U¦ì¤j¤j©Ò¦ôºâªº"822Àø®Ä"¡A¼í®õ¥þ¦ÛµM·|ª¾¹D¦Ó¥B§ó¦h¨Ó¦Û²Ä¤@¤âªº®ø®§ §A¥á§Ú¾ßªºÀ¸½X¤£®É¤Wºt¡A®ü¤j¤áY¥þ±ºM¥X¥xªÑ¡A¤]¦³¥i¯à¥Î¥~¸êªº¦W¸q¶i¨Ó¡A ·í³°ªÑ´äªÑ¥ð®§®É¡A¤]·|¦³¥D¤O¦^Âk¥xªÑ¡A¼ö¿ú¬Ýªº¬O§ë¸ê¾÷·|¡A ·í³°ªÑ¥»¯q¤ñ¤w¸g¶W¹L50¿¡A100¿¥H¤Wªº¤ñ¤ñ¬Ò¬O¡A¥xªÑ¥»¯q¤ñ¥u¦³18¿ªº±¡§Î¤U¡A¥xªÑ¥u¬OÀs§x²LÅy¦Ó¤w §ó¦óªp®ü¤j¤á½æ±¼«á¡A¦pªG´«¨Ó§ó¦hªø½uªº§ë¸ê¤H©Î¥D¤O¶i³õ¡A¤]³\§ó¦n¤]»¡¤£©w ¯E¹©¬O§_¯à¥Ï±¼¤WÂd±q400¶^¤U¨Óªºµ~¹Ò¡A6/3¬Ý±i¸³¯à§_´£¥X¥O¤H®¶¾Äªº¼Æ¾Ú´Nª¾¹D¡A¤£»Ý©ú¥Ü¡A ¥un³zÅS´_µo¤H¼Æ¤j¬ù¦h¤Ö´N¥i¨£ºÝÙ¡A822 PFS³\¦h¯E¤Í³£·|ºâ¡A ©ÎªÌ¬O§ó©ú½T³zÅS¹wp¸Ñª¼®É¶¡»P¸Ñª¼±ø¥ó(Á`´_µo¤H¼Æ)¡A¤]³£¥i¥Hºâ¥X¨Ó ±i¸³¶¯¤ß§§§Ó¡A¦U¦ì¯E¤Í¤]n±¡¸q¬Û®¼¡AÃéê¦í¡A ®É¶¡¨ì¤F¡A¤U¤@¶¥¬q¡AªÑ»ù¸Ó¦h¤Ö¦ÛµM´N·|¦h¤Ö¡A¦hª§ÅG¤]µL·N¸q ¨ì®ÉÔ·|¬O¯Q¾~©Î¬O¤ÑÃZ¡A®É¶¡·|ÃÒ©ú¤@¤Á ====================================================================================== 2915)¼í®õ¥þ¤½§i¥»¤½¥q¨ú±o¥xÆW¯E¹©¥Í§ÞªÑ¥÷¦³¤½¥q´¶³qªÑªÑ²¼ 1.ÃÒ¨é¦WºÙ:¥xÆW¯E¹©¥Í§ÞªÑ¥÷¦³¤½¥q 2.¥æ©ö¤é´Á:104/3/31~104/5/8 3.¥æ©ö¼Æ¶q¡B¨C³æ¦ì»ù®æ¤Î¥æ©öÁ`ª÷ÃB: ¥æ©ö¼Æ¶q910,000ªÑ ¨C³æ¦ì»ù®æ332.28¤¸ |
|
|
·|û¡G²q·Q10136148 µoªí®É¶¡:2015/5/7 ¤U¤È 01:16:38²Ä 265 ½g¦^À³
|
Cliff¤j Iriswu¤j ¹«¤j ÁÂÁÂ参¦ìªº´£ÂI¤Î¸ê°T Á¿¨ìªÀ·|ªººØºØ ¤£´£¤]½} ¬Fªv§ó¤£·Q´£ ¤p§Ì²{¦b¤~²M·¡ ì¨Ó¤å¦rº»´N¬O¥L§r ¦¨´N¤@Ó¤H¯uªº«ÜÃø ¦ýn·´±¼¤@Ó¤H¤Ó®e©ö¤F Åý§Ú̬èë»{¯uªº¥L¨S¨Æ! ÁÂÁÂ参¦ì ¤]ÁÂÁ¤j®a! |
|
|
·|û¡G¯ä¦Ñ¹«10139175 µoªí®É¶¡:2015/5/7 ¤U¤È 12:45:55²Ä 264 ½g¦^À³
|
²q·Q¤j ¤j¤á¤j¬ù³Ñ2000±i¯E¹©¡A³o¨â¤Ñ¥ð§L¡AÂଵ§Ì§Ì¡A®Ú¾Ú¤p§Ì¦³·Çªº¹q¸Ü½u¡A¤j¤á¥þ±±q¥xªÑ©â¸êª÷¡A¤£¬O¥u°w¹ï¥Í§ÞªÑ¡A³Ìªñ·|¤ñ¸û¥Î¤O¦b§Ì§Ì¨¤W¡A¥i¯àÁÙn§Ô@3000±i¡A®Ú¾Ú¤p§Ì¥t¤@¤ä«Ü·Çªº¹q¸Ü¡A¦³¦ì¤ñ®ü¥ý¥Í¦³¿úªº¤H¨C¤Ñ¥[½X¤d¸U¸êª÷¡A¤p§ÌÁÙ¦b°lÂܬd¸ß¤¤¡A®e¤p§Ì¦h¥´´X¤ä¹q¸Ü¦h°lÂÜ´X¤Ñ¦A¦V±z³ø§i ÁÙ¦³¡A®ü¥ý¥Í§i¶D¤p§Ì¡A¥L¤£©M¤Ñ¤W¸ªº¸V³¾»¡¸Ü¡A¦]¬°¶Ç»¡¤Ó¶§¯«ªüªiù¾i¤F¤@°¦¯Q¾~³Ì·R»¡ÁÀ¡C¦³¤@¦¸¥Ñ©ó¯Q¾~»¡ÁÀ¡Aªüªiù»~±þ¤F¥Lªº©d¤l¬ì¬¥¥§´µ¡A¨Ï¥L¥Ç¤F¤£¥i®¾¦^ªº¿ù»~¡C¯Q¾~¦]¦¹³Q»@±N¨¤Wº}«Gªº»È¥Õ¦â¦Ð¤òÅܦ¨¶Â¦â¡A¨Ã¥Ã¨ü°®´÷¤§W¡C¦Ü¤µ¯Q¾~ªº¦Ð¤ò¬O¶Âªº¡A¦Ó¥B¥sÁn¼R°×ÃøÅ¥ |
|
|
·|û¡GIriswu10136250 µoªí®É¶¡:2015/5/7 ¤U¤È 12:26:19²Ä 263 ½g¦^À³
|
²q·Q¤j±z¦n,§Ú¦Û¤v±Àºâ¤j¤áªº«ùªÑ¬ù2350±i(³o¥]§t¤§«eªº²{¼W»{ªÑ).¤£¹L¤j¤á³oºØ²Mܦ¡ªº½æªkÁÙ¯uÅý§Ú¶^¯}²´Ãè¤F.¦ý³£¤w¸g§Ö¹L¥h¤F.¾ã²z¾ã²z«á´N¬O°ò¥»±»¡¸Ü¤F.³o¸Ì·PÁ¦h¦~¨Ó¬°°ò¥»±§V¤Oªº¦U¦ì¤j¤jÌ. |
|
|
·|û¡GCliff10135274 µoªí®É¶¡:2015/5/7 ¤W¤È 11:46:47²Ä 262 ½g¦^À³
|
²q·Q¤j¡A±zªø´Á±Mª`©ó°ò¥»±ªº¬ã¨s¡A±j¯P«Øij±znŪ¤@Ū¤é²±±i¸g²z4/27ªºÂ²³øÀÉ¡A·|¦³¤@·s¦Õ¥ØµeÀsÂI·ú¤§®Ä¡C¦Ü©ó¦p¦ó¨ú±o¡K¡K¦³Ó¤èªk´N¦b¯E¹©°Q½×°Ï¡u¤é²±µû¦ô³ø§ipart.2¡vª©ÀY¤åùØ¡AŪ¥¦¤T¦¸¡AÁo©ú¦p§AÀ³¦³µª®×¡CEnthusiastic as he is, may give U best response. Ó¤H»{¬°³o¼ËÄ@·N¥Î¥\¥B´±¾Ú¡u²z¡v®Â½Ã²z·Qªº¤H¡AÀ³¸Ó¦h¦h¨ü¨ì¹ªÀy¡A¤µ¤é¤@±À¡A¥i¯à¦]¦¹³y¦¨¥L¤p¤p¤@°}¦£¡A¦ý¬O·å¤£±»·ì¡A¹F¦¨¥ô°È®É°O±o¦hÁÂÁÂ¥L¡C¡]·Q·Q¬Ý¡A¥Î¤å¦rº»¹ï«Ý³o»ò»{¯uªº¤H¦³¦h»ò´Ý§Ô¡I¡^ |
|
|
·|û¡GD§b10139065 µoªí®É¶¡:2015/5/7 ¤W¤È 11:10:29²Ä 261 ½g¦^À³
|
¹ê¤O¶¯«pªº¤½¥q¤£§Æ±æ¥L¦bªÑ»ù¤W¤U¨ä¤â¡A¦n»E¦n´²¡F¨SÔ£°]°ÈI´ºªº¤½¥qµøª÷¥D¬°¤W»«¡A¤Þ§g¤JÂ|¤Ñªø¦a¤[¡I |
|
|
·|û¡GD§b10139065 µoªí®É¶¡:2015/5/7 ¤W¤È 11:03:21²Ä 260 ½g¦^À³
|
½Ð°Ñ¦Ò2015-05-01 11:15:36 ¸gÀÙ¤é³ø ¥»³øºî¦X³ø¾É http://money.udn.com/money/story/5607/874958-%E5%8F%B0%E8%82%A1%E4%B8%89%E5%A4%A7%E5%A4%A9%E7%8E%8B-%E6%94%B9%E8%B2%B7%E6%88%BF%E3%80%81%E8%B2%B7%E9%99%B8%E8%82%A1 |
|
|
·|û¡G²q·Q10136148 µoªí®É¶¡:2015/5/7 ¤W¤È 10:25:30²Ä 259 ½g¦^À³
|
ÁÂÁ Faith ¤j ¼ö¤ß¦a´£¨Ñ¸ê®Æ ¤p§Ì·Qª¾¹Dªº¬O ¬Y¥|Ó¤ÀÂI¨ì©³ÁÙ¦³¦h¤Ö®w¦s ³o¥|Ó¤ÀÂI¦b¯E¹©¤WÂd«á ¤w½æ¥X¤T¤d¥|¦Ê¦h±i ¤p§Ì°O±oIriswu¤j §i¶D§Úªº®ÉÔ¬O»¡ÁÙ¬ù4000±i ¥u¬O¤p§Ì§Ñ¤F±N®É¶¡°O°_¨Ó ²{¦bµL±qpºâ®w¦s ³Ìªñ´X¤Ñ ³o¥|Ó¤ÀÂI¨gÅF¥S§ÌÀÉ ¯u¤£ª¾±z¤j¤á ¤ß²z¦b¥´ºâ¤°»ò?! ÁÂÁ Faith ¤j ¤]ÁÂÁ¤j®a! |
|
|
·|û¡GFaith10138335 µoªí®É¶¡:2015/5/7 ¤W¤È 09:57:41²Ä 258 ½g¦^À³
|
²q·Q¤j ¦A¸É¥R¤@¤U ¤W±¥i¥HÂI¿ï «ùªÑÅÜ¤Æ ©Î ªÑªF¤H¼Æ ©Î ªÑªFµ²ºc... |
|
|
·|û¡GFaith10138335 µoªí®É¶¡:2015/5/7 ¤W¤È 09:53:06²Ä 257 ½g¦^À³
|
²q·Q¤j §ä¨ì¤F ±z¬Ý¬Ý¬O¤£¬O³oÓ http://stock.nlog.cc/c/4174/1 |
|
|
·|û¡GFaith10138335 µoªí®É¶¡:2015/5/7 ¤W¤È 09:50:18²Ä 256 ½g¦^À³
|
²q·Q¤j ±z¦b§äªº¬O³oÓ¶Ü?(ÁÙ¦³¤@Ó§ó²M·¡ªºª©,§Ú§ä¤@¤Upoµ¹±z) http://tsjh301.blogspot.tw/2014/08/obipharma.html?m=1 ¥t¥~¤½¶}»¡©ú®Ñ¤¤ 4¤ë1¤é³Ì·s¤º®e ¦³´£¨ì«e10¤jªÑªF ®}.³\³£¦bº]¤W ²Ä10¦W1997±i ªGµM¦p¯E¤Í©Ò¨¥ ÃѳfªÌ¦ÀR®¨®¨ªº¦b¦Y³f¤F ¯Î°|ªø¤SÀò¼ú¤F,¥L¤]¨üÁܨì^°êºtÁ¿,§Æ±æ¯àÂǦ¹º¡ºCºC¥´¶}°ê»Úª¾¦W«× ¯E¹©¥[ªo ÀRÀRµ¥«Ý¤¤~~ |
|
|
·|û¡G¦n¤ßªº¯Q¾~10137878 µoªí®É¶¡:2015/5/7 ¤W¤È 09:12:31²Ä 255 ½g¦^À³
|
¤¤¸ÎÁÙ¦b¯}©³ ·sÃĪÑÁÙ¨S¶^§¹ ®Ú¾Ú¦~½u¦©©è ¦Ü¤ÖÁÙ¦³3-6Ó¤ë¥i¥H¶^ |
|
|
·|û¡Gmoncler4710135258 µoªí®É¶¡:2015/5/7 ¤W¤È 09:09:09²Ä 254 ½g¦^À³
|
½æÀ£¤w¸gµ²§ô¤F2¤Ñ,±µ¤U¨Ó´N¬O"º¥¤J¨Î¹Ò"... |
|
|
·|û¡G²q·Q10136148 µoªí®É¶¡:2015/5/7 ¤W¤È 09:01:08²Ä 253 ½g¦^À³
|
Cliff ¤j ¦nºë±m! ª¾ÃѲW³Õªº±z ¼g¥Xªºµû½×¤å³¹ ´N¬OÅý¤HÅå¼Û! «D±`·PÁ±z! ¥i±¤¤p§Ì¹M´M¤£µÛ±i¥ý¥Í4/27ªº¬ã¨s³ø§i ¤£µMÀ³·|§óı¬Û±o¯q¹ü °J¤ß´Á¬ß¥H«á¯à±`¬Ý¨ì±z³oºØ¦³ª¾ÃѩʤS±a¦³µûªRªº¤å³¹ ¦³±z³o¼ËµL¨p¦a¤À¨É ÁÙ¦³¸ÑªR822¾÷Âà©Ò±aµ¹¤j®aªº«H¤ß ¯u¤£ª¾¸Ó¦p¦ó¨¥Á ¦A¦¸·PÁ±z! ³Ìªñ±z¤j¤áªº·«B ´X¥G±½ºÉ¥L¦³«ùªÑªº¼Ðªº «e¬q®É¤é ·PÁ Iriswu ¤j©Ò´£¨Ñªº±z¤j¤á«ùªÑª¬ªp ¦ý¤p§Ì§Ñ¤F¬O¦ó®Éªºªº¨Æ±¡¤F ¬Q¤éªá¨Ç®É¶¡ ¦ý»¡¤]©_©Ç ³ºµM§ä¤£¨ì ¥i§_½ÐIriswu ¤j ¦A·Ð³Ò¤@¤U À°¤p§Ì¸Ñµª¤@¤U ÁÂÁ±z! ¤S¦b´M§ä¤¤ ¤]¬Ý¨ìIriswu ¤j ¦³Ãö822»P§C¾¯¶qcyclophosphamide¬O§_·|¦³Áp¦X¥ÎÃĪº°ÝÃD ¨Ì¤p§Ì¬Ýªk 822À³¤£·|¨ü¨î©ó¤H ¤£ºÞ¬Ocyclophosphamide ÃÄ«~¨ú±o©Î¬O»ù®æ ¦]¬°¬O¾Ç¦WÃÄ 500mg ¥x¹ô¤@¨Õ¦h¤¸ ¹ï±wªÌÀ³¤£¬Ot¾á ÁÂÁÂIriswu ¤j´£¨Ñ±z¤j¤áªº«ùªÑ²Öp ÁÙ¦³ÃÒ©Òµ|ªº¸Ñ»¡ ·PÁ¨â¦ì ¤]ÁÂÁ¤j®a ! |
|
|
·|û¡GFaith10138335 µoªí®É¶¡:2015/5/6 ¤U¤È 06:20:09²Ä 252 ½g¦^À³
|
¥xÁÞ¤j ÁÂÁ±z´£¨Ñªº¸ê°T Cliff¤j ±z¯u´Î ¤p§Ì¤âÃäÁöµL³o¨Ç³ø§i ¦ý¬Ý±zªºpo¤å¡A´Nª¾¹D±z¤w§â«ÂIµ¹ÂI¥X¨Ó¤F ÁÂÁ±z |
|
|
·|û¡GCliff10135274 µoªí®É¶¡:2015/5/6 ¤U¤È 05:28:29²Ä 251 ½g¦^À³
|
¥xÁÞ¤j¡G ¹ï§Ú¦Ó¨¥¤ñ¸û¦Õ¥Ø¤@·sªºË¬O§âGHCer·í§@¬O¤@Óimmune checkpointªº³o¤@¶µ¡C¦Ó¡userving as a cancer antigen (including breast cancer stem cells)¡v¤Ï¦Ó¬O³Ì°ò¥»/³Ìªìªº·§©À---GH¤£´N¬O±q¨ÅÀù²ÓM¤Wµo²{ªºÁÞ§Üì¶}©l³Q¤F¸Ñªº¶Ü¡H¡K¡K ³¯¹a¬z³Õ¤h¦b2014/12/04¦b¤¤¬ã°|¤]°µ¹L¤@¦¸ºtÁ¿¡A¥i¯à¨º¤@¦¸ªº¤º®e¸ò2015/05/07ªº¤º®e´N¤ñ2010/05/15ªº¤º®e§ó¬°±µªñ¡C¦U¦ì¦³¿³½ìªº¸Ü§â¤é²±§ëÅU±i¤ÀªR®v¦b2015/03/23»P2015/04/27ªº¤ÀªR³ø§iŪ¤@Ū¡A¤×¨ä¬O4/27ªº¡u600»õ¡A6000»õ¡HÁÞ¤À¤l¬Ì]»P¯E¹©ªº¼ç¤O¡vùØ¡A´N¦³±M¶´£¨ì¤F¡u¡KGlobo H¹ê±a¦³Ãþ¦üPD-1ªº¤Ï«b¨®¾÷¨î¡v¡AºK¿ý¨ä¤¤¤@¥y¡u¡K·íGlobo H ³Q822²£¥Íªº§ÜÅé²¾°£¡A§K¬Ì²ÓM´N¤£·|§]¤JGlobo H³oºØ¦w¯vÃÄ¡A¦Ó¬O¥h±þ¦º±a¦³³oºØ¦w¯vÃĪº¥ô¦ó²ÓM¡C¡v ¥Ø«e°ê¤º¦U®a§ëÅU¥Xª©ªº¯E¹©µû¦ô³ø§i¡A¥H¥Lªº¤º®e³Ì²`¤J/³Ì§¹¾ã¡A¦³¤H»¡¥L³Ì´±§â¯E¹©µû°ª»ù¡A§ÚËı±o¦]¬°¥L°÷¥Î¥\¡A¨C¥÷³ø§i¤]³Ì¨ã»¡ªA¤O¡A¤£¬O¾ÌªÅ°_¥ä¶Ã³Û»ùªº¡A«Øij³ÛªÅ©Î¤£À´ªº¤H¥h§ä¨Ó¦n¦nŪ¤@Ū¡C ¦Ó¥Ø«e°ê»Ú¶¡¦³Ãöªº¤åÄm°Q½×¡A¥un´£¨ìimmune checkpoint¡A´X¥G³£¬O°Q½×PD-1/PD-L1¡A¨S¦³¤H§âGlobo H¦Ò¼{¶i¥h¡A¤]´N¬O¥L©Ò»¡ªº¡u¡K°ê»Ú¹p¹F©|¥¼±½¨ì³o¤@¶ô¡K¡v¡A§ÚÓ¤H¬Û«H¸Ñª¼«áªº¼Æ¾Ú±N·|±a°ÊStorm of Globo H¡AÅý¬ã¨stumor antigen of Globo H series¦¨¬°Åã¾Ç¡C ¥H«e¶K¹LªºÂ¸ê®Æ¡AÅý±ß¶iª©¦Ó¦³¤ß¤F¸Ñªº¤H½m¥\¡G ¡]¶i¡u»OÆW³ÕºÓ¤h½×¤åª¾ÃÑ¥[Ȩt²Î¡v«á¡A¥H§@ªÌ·j´M¥ç¥i¡C¡^ ¤¤¤åºKn¡G¡]immune checkpoint¡^ Àù¯g¬ÛÃöÁÞ§ÜìGlobo H¹ï©ó§K¬Ì²ÓM¬¡¤Æ»P¤ÏÀ³¼vÅT¤§¬ã¨s¡CBy ½²©öË¡¡]http://handle.ncl.edu.tw/11296/ndltd/90454609930207165570 ¡^ ^¤åª©«ÜÃøŪ¡G A Prevalent Cancer Associated Glycan, Globo H Ceramide, Induces Immunosuppression by Reducing Notch1 Signaling. J Cancer Sci Ther 2013;5:264-270 ¡]http://www.google.com.tw/url?url=http://omicsonline.org/1948-5956/pdfdownload.php%3Fdownload%3DJCST-05-264.pdf&rct=j&frm=1&q=&esrc=s&sa=U&ei=SNpJVdLNPMTAmwW7lYDAAg&ved=0CBgQFjAB&usg=AFQjCNFbR4hXB70RL5CElXMAWKAVgFcS2g ¡^ ÁÙ¦³¡]GH·|«P¶iÀù²ÓM¦åºÞ¼W¥Í-as an angiogenic factor¡^ «P¶i¦åºÞ·s¥Íªº Globo-H Ceramide ¤Î¨ä¤À¤l¾÷¨î¤§±´°Q¡CBy µ{´º«Û ¡]http://handle.ncl.edu.tw/11296/ndltd/82440589060245466220 ¡^ ²Ä¤TÓ¡G¡]as a cancer antigen (including breast cancer stem cells)¡^ ³oÓÀ³¸Ó¤£¥Î¤F§a¡H¦Ñ½Õ¤ú¤F¡C ¡]http://www.genomics.sinica.edu.tw/2013/index.php/tw/news/news-archives/197-2009-09-08-09-12-55¡^ |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2015/5/6 ¤U¤È 01:23:09²Ä 250 ½g¦^À³
|
¯Î±Ò´fÀò¹{^°êù»«»¹¼ú 2015/05/06 12:24¡]¤¤¥¡ªÀ°OªÌ³¯¦Ü¤¤¥x¥_6¤é¹q¡^ ¤¤¥¡¬ã¨s°|°|ªø¯Î±Ò´fÀò±o^°ê¬Ó®a¤Æ¾Ç·|¹{µo¡uù»«»¹¼ú¡]Robert Robinson Award¡^¡v¡Aªí¹ü¥L¦b¤Æ¾Ç»P»Ã¯À¦X¦¨¤èªkªº°^Äm¡C ^°ê¬Ó®a¤Æ¾Ç·|¬O¤@Ó«DÀç§Q¾Ç³N²Õ´¡A³Ð¥ß©ó1841¦~¡A¾Ö¦³5¸U¦h¦ì·|û¡Cù»«»¹¼ú«h¬O1964¦~¶}©l¹{±Â¡Aªí¹ü¤Æ¾Ç¾ÇªÌªº¾Ç³N¦¨´N¡AºI¦Ü¤µ¦~¦@¦³30¦ìÀò¼úªÌ¡C ¯Î±Ò´f¬O¥@¬É¤Wº¦ì¦¨¥\¥H»Ã¯À§Þ³N¡A¤j¶q¦X¦¨½ÆÂø¦hÁÞÅé¤ÎÁÞ³J¥Õªº¬ì¾Ç®a¡A¨Ãµo©ú¡uµ{¦¡¤Æ¤@Á禡¤ÏÀ³¡v¡A¬O¥Ø«e¬ì¾Ç¬É°ß¤@§Ö³t¦X¦¨¹èÁÞªº¤èªk¡C ^°ê¬Ó®a¤Æ¾Ç·|»{¬°¯Î±Ò´f¦bµo®i¤Æ¾Ç»P»Ã¯À¦X¦¨¤èªkµ¥¦³°^Äm¡A¤×¨ä¬OÁA¸ÑÁÞ¤À¤l¦b¥Íª«Å餤§êºtªº¨¤¦â¡A¶}³Ð¤FÃĪ«¬ãµoªº·s«´¾÷¡A¦]¦¹¹{µ¹¥Lù»«»¹¼ú¡C ^°ê¬Ó®a¤Æ¾Ç·|¨Ã±N¦b¥¼¨Ó¤@¦~¤º¡AÁܽЯαҴf¨ì^°ê4©Ò¤j¾Çµoªí±M·~ºtÁ¿¡C |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2015/5/6 ¤U¤È 12:27:02²Ä 249 ½g¦^À³
|
¸É¥R»¡©ú»P§ó¥¿ 쥻¥H¬°GHCer ªº¨¤¦â¥u¨âÓ: A À£¨îT²ÓMªº§K¬Ì¬¡©Ê( serving as an immune checkpoint ) B «P¶iÀù²ÓM¦åºÞ¼W¥Í ²{¦b¤S¦hµo²{¤@ÓC:§êºt§Ü쨤¦â,¨ä¥LÁÙ¦³SSEA3(Gb5)¦b¨ÅÀù¨ÅÀù·F²Óªí²{>60%,³oÓ¬ã¨s®¶¾Ä¼Ö¥Ø«eªº¤G¤T´ÁÁ{§É.. ±qÁ¿ºõ±À´ú²Ä¤T¥N¬Ì]·|¥HGlobo H¬°§Üì , DT¬°¸üÅé³J¥Õ½è, C34¬°¦õ¾¯ ( ¥u§ï¦õ¾¯ ,¤£n¤@¦¸§ï¨âÓ) |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2015/5/6 ¤W¤È 11:21:09²Ä 248 ½g¦^À³
|
¹Ç§AÅó±ø±ø¤j 1§A©P¥þªº¦Ò¼{«Ü¦³¨ì²z,ÄÝ©ó§Æ±æ¤@Á|¦¨¥\ªºÃ°·¸Ñª¼§ë¸ê¤H,«Ü¦h¤j¤j»P§A¦³¦P¼Ë·Qªk,§Ú·|²q´ú´£«e¬O°£¤FÃĮĥ~,°ò©ó¥~¦b¨ä¥L¦]¯Àªººî¦X¦Ò¶q,¤£¬O±qK-M¦±½u»P0.5¬Û¥æ³oÓ¨¤«×¨Ó¬Ý,¦]¬°822ÃĮĨâ²Õ®t¶Z¹L¤j,¤~¦³´£«eªº±ø¥ó,¦pªG¬OÃĮĴ¶´¶ªºÃÄ´N¨S¦³´£«eªº±ø¥ó,§A°O¤£°O±o3¤ë3¤éªk»¡®É:ÃÄ®Ä100% improvement ´c¤Æ120¤H´N¥i¸Ñª¼(±À´ú¬O«ü¹êÅç²Õ)±q¹ê»Ú±¡ªp¨Ó¬Ý,½Ð¦U¦ì¤j¤j«ä¦Ò¤@Ó°ÝÃD:¹êÅç²ÕªºÃĮĥu¦³100% improvement¶Ü? ¦pªG¤£¬O100%¦Ó¬O200% ·|°¨ì¦h¤Ö¤H?(¨ä¹ê§Ú¤]¤£ª¾¹D,100%improvement PFS ¬O12Ó¤ë , 200% improvement PFS ¬O18Ó¤ë ) 2¬Û«H¯E¹©ªº¸gÅç»P±M·~»PÁ{§ÉÅU°Ý,¦pªGÁ{§ÉÅU°Ý±M®a¬ã§P¥i¥H¸Ñª¼¨º´N¤ô¨ì´ë¦¨,¥H¨º¨ÇÁ{§ÉÅU°Ý±M®aªº¸gÅç¦pªG¬ã§P¥¿½T,¥H±j½Õ¯à¤O»PÁZ®Äªº¨¤«×¨Ó¬ÝÅU°Ý¶O¥Î¥²©w¦h«Ü¦h 2 Cliff¤j´£¨Ñ³¯¬Â¬z³Õ¤hªºªñ´ÁºtÁ¿,¤S¦³«¤jµo²{,쥻¥H¬°GHCer ªº¨¤¦â¥u¨âÓa À£¨îT²ÓMªº§K¬Ì¬¡©Ê¤Î b «P¶iÀù²ÓM¦åºÞ¼W¥Í ²{¦b¤S¦hµo²{¤@ÓC §êºt§Ü쨤¦â,¨ä¥LÁÙ¦³SSEA3 Globo H ¦b¨ÅÀù¨ÅÀù·F²Óªí²{> 60 %,³oÓ¬ã¨s®¶¾Ä¼Ö¥Ø«e±o¤G¤T´ÁÁ{§É.........) ¬P´Á¥|«áÀ³·|¦³»á®¶¾Ä¤H¤ßªº¸ê°T¥X²{ ( ¨ÅÀù·F²Ó³QÄè·À¨ÅÀù¤~¦³®Úªvªº¾÷·|) GHCer plays triple roles in serving as a cancer antigen (including breast cancer stem cells), as an immune checkpoint and as an angiogenic factor, thereby propelling the ongoing multi-national phase II/III clinical trial of globo H vaccine in breast cancer. ¥H¤W²L¨£´£¨Ñ°Ñ¦Ò ,¦p¦³»~½Ð§ó¥¿ , §ë¸êª`·N·ÀIºÞ²z |
|
|
·|û¡G¹Ç§AÅó±ø±ø10135894 µoªí®É¶¡:2015/5/6 ¤W¤È 09:57:57²Ä 247 ½g¦^À³
|
¤p±j¤j¡A ±zªº°ÝÃD¬O¨CÓ¯E¤Í³£·Qnª¾¹D¤F¸Ñªº¡A¥u¬O¸g¹L®a¸V¨Æ¥ó«á¡A±i¸³À³¸Ó¤£·|³zÅS¤Ó¨ãÅ骺¸ê®Æ¡A¥u¯àÁr´ú§a...«¢«¢ ±qÄw½X±¨Ó¬Ý¡A2014/5~2015/5, «ùªÑ1000±i¥H¤W¤H¼Æ±q48¤H´î¨ì38¤H¡A4¤ë¥÷¤S´î¤F2Ó¤H ¨ä¥L¤pªÑªF¤H¼Æ¬O¦b¼W¥[ªº¡A©Ò¥H¥ý«eªÑ»ù³n¸}À³¸Ó¸ò¥D¤O¤j¤á°§C«ùªÑ¦³Ãö ¤UÓ¤ënªÑªF·|¡A·Pı¶R½L¤S¦³³°Äò¦^Å¢ªº«ººA¡A¦Ó¥B¥Í§ÞªÑ¤]³£¤w¶^²`¡A§Æ±æ¯à°÷¨«¥X³±ÅµºCºCº¦¦^¥h ¥xÁÞ¤j¡A ¦P·N±z»¡ªºÃĮĦpªG®É¤ÀÀu²§¡A¤½¥q¬O¥i¥H´£«e¸Ñª¼¡A¤£¹L³]¤H¼Æ¤]¥²»Ýn³Q¥R¤À¦Ò¼{ ¥H§KK-M¦±½u»P0.5¬Û¥æªºPFS¤£¦p¹w´Á¡A ©Ò¥H§Ú»{¬°ÁÙ¬O©ú¦~¤¤(2016¦~8¤ë?)³Ì¦³¥i¯à: 1.©Ò¦³¨ü´ú¸ÕªÌ§¡¥i¥H¦³24Ӥ몺Á{§É¸ÕÅ禨®Ä 2.¹ï·Ó²ÕOS«Ü¥i¯à¤]¥i¥Hµe¥X¨Ó¤F Ó¤H²z¸ÑY¦³¥X¤J¡A½Ð¦h«ü±Ð... |
|
|
·|û¡G¤p±j10137673 µoªí®É¶¡:2015/5/5 ¤U¤È 02:21:40²Ä 246 ½g¦^À³
|
ªÑªF·|·Q°Ý ¤½¥q¬O§_¨C¹j¤@¬q©T©w®É¶¡´N·|©MÁ{§ÉÂå®v°Q½×¯f¤H±¡ªp.¬O¨C¹j¦h¤[.³Ìªñ¤@¦¸¬O¦ó®É.¹êÅç²Õ¤Î¹ï·Ó²Õªº°Æ§@¥Î¬O§_©úÅ㤣¦P.¦pªG¬O.³Ìªñ¤@¦¸©MÁ{§ÉÂå®v°Q½×«á¤½¥q¬O§_¯à°÷§PÂ_¥X²{¦b822ªºPFS¬O¦h¤Ö.¦³¤j©ó20Ó¤ë¶Ü. |
|
|
·|û¡G¹Ç§AÅó±ø±ø10135894 µoªí®É¶¡:2015/5/4 ¤W¤È 11:06:37²Ä 245 ½g¦^À³
|
±i¸³»¡¸Ñª¼®É¶¡¥i¯à¸¨¦b¤µ¦~©³¨ì©ú¦~¤¤ªº³o¬q´Á¶¡¡A±qÃĮĤñ¹w´Á¦nªº³oӵﵷ°¨¸ñ¨Ó¬Ý Ó¤H¶É¦V©ó»{¬°«áªÌ¡A¤]´N¬O©ú¦~¤¤¤~·|¸Ñª¼¡C ±i¸³»¡Ó¤µ¦~©³¬O¥ý¦w¤@¤U¤j¦h¼Æ§ë¸ê¤Hªº¤ß¡A¦pªG3¤ë®É»¡n©ú¦~¤¤¸Ñª¼¡A«Ü¦h¤H¤j·§nºÆ¤F ©Ò¥Hµ¥¨ì8¤ë¦A©µ¤@¤U®É¶¡¨ì©ú¦~....²¦³º³\¦h§ë¸ê¤H¬Æ¦Üªk¤H¤]¬O¬Ýªº«Üµu§r ©ú¦~¤¤¸Ñª¼®É¡A³Ì«á¤@Ó¦¬®×¤H¤]¦Ü¤Ö¸g¹L20Ó¤ë¡A¥B´_µo¤H¼Æ«Ü¦³¥i¯à·|"²Îpªº¼Æ¾Ú¤~¦³·N¸q" ¥B©IÀ³¥xÁÞ¤j±q¤@´Á¹w¦ô822 PFS 32~36ªºÃĮĵ²ªG¡C Á`¤§¨ì¤UÓ¤ë¦pªG±i¸³Ä~Äò©ñ¥X¦n®ø®§¡A¦U¦ì´N»Ýn©ê§óºò¤@ÂI¡A¤£n¦~©³°_º¦°_¸¤F´N³Q¬~¥X¥h http://news.ltn.com.tw/news/business/paper/859885 "¯E¹©¥Í§Þ¥HÁÞ¤À¤l¬°®Ö¤ß§Þ³N¡A¶}µo·sÃÄ¡A¥Ø«e¶i«×³Ì§Öªº´N¬OOBI-822¡A°w¹ï¥½´Á¨ÅÀù¯f±w©Ò¬ãµoªº¨ÅÀù¬Ì]¡A¦b¥h¦~8¤ë©³¤w¸g¦¬¨¬²Ä2¡B3´ÁÁ{§É¸ÕÅç©Ò»Ýªº349¦ì¯f±w¡A¯E¹©¸³¨Æªø±i©À·O«ü¥X¡A¤µ¦~8¤ë¡A³Ì«á¤@Ó¯f¤H§¹¦¨12Ӥ몺Àøµ{¡A¤½¥q´N¦Ò¼{¦ó®É¸Ñª¼¡C ±i©À·Oªí¥Ü¡A¿ï¾Ü¸Ñª¼ªº®É¶¡ÂI«Ü«n¡A¥²¶·´_µoªº¯f¤H¨ì¤@©wªº¼Æ¥Ø¡A²Îpªº¼Æ¾Ú¤~¦³·N¸q¡A¥Ø«e´_µoªº¤H¼Æ¤ñ¹w¦ôªº¤Ö¡A¸Ñª¼ªº®É¶¡¥i¯à¸¨¦b¤µ¦~©³¨ì©ú¦~¤¤ªº³o¬q´Á¶¡¡C ±i©À·Oªí¥Ü¡A´_µo¤H¼Æ¤ñ¹w´Á¤Ö¡AÅã¥ÜOBI-822ªº½T¬O©¹¨ã¦³Àø®ÄªºÁͶը«¡A¤@¥¹¸Ñª¼µ²ªG¦p¹w´Á¦³®Ä¡A±i©À·Oªí¥Ü¡A±N·|¦b3~6Ӥ뤧¶¡°e¥óTFDA¥Ó½ÐÃÄÃÒ¡A¦Ü©ó¯à¤£¯à³z¹L§Ö³t¼f¬d®³¨ìÃÄÃÒ¡A«hn¬Ý¼Æ¾Úªº¦nÃa¡C" |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2015/5/3 ¤W¤È 07:42:06²Ä 244 ½g¦^À³
|
Åó±ø±ø¤j Faith ¤j ¨£¯E¹©·s»D¤¤¤ß©x¤èªO (¯E¹©¥Í§Þºô¯¸)¡A¸Ñª¼¬O¦b³Ì«á¦¬®×¯f¤H§¹¦¨Àøµ{«á¡A¨Ì¾ÚÓ¤H±À¦ô¤µ¦~¤¤ë·|§¹¦¨³Ì«á¤@¦ì¯f±wªºÀøµ{¡A²Îp¤ÀªR»Ýn3Ó¤ë¡A·í¤µ¦~8°Á{«á«KÀH®É¥i¶i¦æ¸Ñª¼¡A¯E¹©ªºÁ{§É¤è±ªº±M·~ÅU°Ý¦bµ¥«Ý¤@ӳ̨ÎPFS ªº®ÉÂI¨Ó¸Ñª¼¡A¤]´N¬OÃöÁä°Ï¶¡ªº´c¤Æ¯f±wµû¦ô¬O¨Ó¦Û2011¦~ªº¯f±w |
|
|
·|û¡Gsummer10000119 µoªí®É¶¡:2015/5/3 ¤W¤È 03:41:23²Ä 243 ½g¦^À³
|
Åó±ø±ø¤j¡G ¦P·N§A©Ò»¡ ¡§Y8¤ë¨M©w¦b2015¦~©³©Î2016¦~¬YӮɶ¡¸Ñª¼¡A³]¸ê®Æn"ÁקK"¤j¶q¸¨¦b±À¦ôPFS¥H«eµo¥Í¥H§K¦s¬¡²v³QÄY«¤zÂZ¡¨ ¦pªG¤½¥q±À¦ôpfs¬OÁÙ¤£¿ùªº±¡§Î¡A§Úı±o¯à¥Î¸Ñª¼®ÉÂI±±¨îªº¡u¥¼´_µoªº³]¸ê®Æ¡vn¶V¤Ö¤ñ¸û¦n¡A¥H§K³Q«á´Á¦¬®×ªº¡u¥¼´_µoªº³]¸ê®Æ¡v¤zÂZ¡C Faith¤j¡G §Ú¥ç¶É¦V¤p©_¤j¤ÎD§b¤j©Ò»¡¥H¦¬®×349¤Hpºâ¡A¤£¹L°w¹ï¦¬®×¤H¼Æpºâ°ÝÃD¡A¦pªGªÑªF¤j·|¥X®uªº¤j¤j¯à°Ý¤@¤U°µÓ½T»{·|§ó¦n¡I ¥t¥~°w¹ï´_µo¤H¼Æ¡A«¢«¢¡I¶W·Qª¾¹D¡A¥i¯à¤j®an¶°«ä¼s¯q¤@¤U¡A¬On«ç»ò°Ý¤ñ¸û¦n? §Ú·Q¤@Ó¡G¡u¤½¥q¶É¦V´X¤ë¨Mij¸Ñª¼?¤SÁ`´_µo¤H¼Æ¦h¤Ö¬O¤½¥qªº¨Mij¸Ñª¼ªùŲ?¡v |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2015/5/2 ¤U¤È 11:44:38²Ä 242 ½g¦^À³
|
¿ù»~¸É¥¿ ¦pªG¹êÅç²Õ90¤H´c¤Æ¡A²Ä46¤H¨ì²Ä84¤H¦b2015¦~2¤ë¶}©l´c¤Æ ³o38¤H·í¤¤¦pªG¬O¨Ó¦Û2012,2013,2014³o¤T¦~´N¤£¥Î¾á¤ß ¦]¬°³o¨Ç¤H·|´¡¶¤±Æ¦b«e±¡A²Ä85¤H¨ì²Ä95¤H°²³]¬OÃöÁä°Ï¬q¡A¯E¹©ªº±M®aÅU°Ý¡A ¨S¦³²z¥Ñ¤£§â´c¤ÆªºÃöÁä10¤H±±¨î¦b¨Ó¦Û2011¦~¦¬®×ªº¨ü¸Õ |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2015/5/2 ¤U¤È 11:25:14²Ä 241 ½g¦^À³
|
PFS ¼Æ¾Ú¦nÃa»P±ß«á¸Ñª¼¤£¤@©w¦³¥¿¬ÛÃö ¸g¹L¤p©_¤jªº¤ÀªR ³ÌÃöÁ䪺±Æ¶¤°Ï¬q³Ì«n¡A¯S§O¬O²Ä85¤H¨ì²Ä95¤HªºÃöÁä°Ï¬q ´c¤Æªº¹êÅç²Õ¬O¨Ó¦Û2011¦~¡A2012¦~¡A2013¦~©Î2014¦~¦¬®× ¦pªG¬O«á±¦¬®×ªº·|±Æ¤J²Ä46¨ì²Ä84¡A¯E¹©À³·|ºÉ¿ìªkn§âÃöÁä°Ï¬q ±±¨î¦b¨Ó¦Û2011¦~¡AÀ³¤£¥u¬OºëÆA´N¨¬¥H¦æ®e |
|
|
·|û¡GD§b10139065 µoªí®É¶¡:2015/5/2 ¤U¤È 10:55:20²Ä 240 ½g¦^À³
|
faith¤j¡G284¤H¯Â´N¬O±i¸³»¡ì³]pn¤ñ¶PÀù¥¦n50%®É¸Ñª¼¤H¼Æ¡AºaÁ`´£¨ìp¹º®ÑùØ´Á¤¤¤ÀªR¨Ì¤p§Ì¬Ýªk¬O¦³¨âӥتº1.¦b¦¬®×¹Lµ{¤¤Y¹ï·Ó²Õ´_µo¤@¥b©M¸ÕÅç²Õ´_µo¤@¥b¥H¤W¡A¤H¼Æ¬ù²ö57+114=171¥H¤W®É(§ì176)¬Ý¤@¤Ukm¨ç¼Æ¯}0.5®É¹ï·Ó²Õ©M¸ÕÅç²ÕªºPFS¦³µLÅãµÛ®t²§¡H2.¨Ã©M284¤H¹ï¤ñ¬ÝÃĮĦ³¨S¦³¦p¸ÕÅç³]pªì³]©wªº¦n¤W50%¡H¦A¨M©w¸ÕÅçn¤£n¶i¦æ¤U¥h¡A©Î¬On°µ×¥¿¡C©Ò¥H¸ê®Æªº·j¶°À³¬O¥H¦¬®×349¤Hpºâ¡A¤£¦¨¼ô¬ÝªkY¦³¿ù»~©|¥B¨£½Ì¡C |
|
|
·|û¡GFaith10138335 µoªí®É¶¡:2015/5/2 ¤U¤È 09:46:48²Ä 239 ½g¦^À³
|
¸É¥R Åó±ø±ø¤j¡A±z¯uÁo©ú¡I ªÑªF·|®É´N¬On³o¼Ë°Ý¤~¤£·|Åý±i¸³¬°Ãø¡I«¢«¢«¢ ¡u¨ì2015¦~5¤ë©Ò¦³¯f¤H³£¥Î§¹ÃÄ«á¡A´_µo¤H¼Æ¬O§_¤w¹F¤§«en´Á¤¤¤ÀªRªº142¤H¡v ¥t¥~¡A¸Ñª¼¬O¥H284©Î349pºâ¡H(³o¨â¶µ¿ï¾Ü¤£¦P·|¼vÅT¸Ñª¼®É¶¡ÂI¡^ °O±o¥H«e¯E¤Í¦³´£¨Ñ¤@¥÷ºaÁ`ªº¸ê®Æ¡A·í®É¤º®e´£¨ì¤½¥qn¥H284¥h°£¦Ó«D342¡]·íªìÁÙ¥¼¦¬¨ì349¡^ ¤p§Ì¤w¦³¨Ç§Ñ¤F¡]°·§Ñ§r¡I¡^ ¦A½Ð°O±oªº¯E¤Í¬ã¨s¬Ý¬Ý |
|
|
·|û¡GFaith10138335 µoªí®É¶¡:2015/5/2 ¤W¤È 10:52:51²Ä 238 ½g¦^À³
|
Åó±ø±ø¤j ¤p§Ì¤]¦³¬Ý¨ì³o¥y ¡u°O±o2¦~«e³Ìªì¬Ý¨ì¤½¥q¹ï©ó822¹êÅçpµe·í®É´N¹wp³Ì«á¤@Ó¦¬®×µ²§ô«á¦AÆ[¹î2¦~«á¸Ñª¼¡v ¦]¬°¬O¦¬®×¶}©lºâ¦Ó«D¥Î§¹ÃĶ}©lºâ ©Ò¥H³ÌºC¬O2016¡B8¤ë¸Ñª¼ ¤p§ÌY¸ÑŪ¦³¿ù¡A¦A½Ð¤j®a¨ó§U§ó¥¿ |
|
|
·|û¡G¹Ç§AÅó±ø±ø10135894 µoªí®É¶¡:2015/5/2 ¤W¤È 08:56:25²Ä 237 ½g¦^À³
|
Y8¤ë¨M©w¦b2015¦~©³©Î2016¦~¬YӮɶ¡¸Ñª¼¡A³]¸ê®Æn"ÁקK"¤j¶q¸¨¦b±À¦ôPFS¥H«eµo¥Í ¥H§K¦s¬¡²v³QÄY«¤zÂZ ¥H¤U¨Ò¦Ó¨¥ ¦¬®×®É¶¡ 2012/12 2013/6 2013/9 2014/4 2014/8 Total ================================================================ Â÷2015/10 34(¤ë) 28(¤ë) 25(¤ë) 18(¤ë) 14(¤ë) ================================================================ ¹êÅç²Õ¤H¼Æ(¦ô) 66 66 20 57 24 233 ¦b2015/10¤ë¥H«e¸Ñª¼ªº¸Ü¡A57+24Ó¹êÅç²Õ³£¥¼º¡18Ó¤ë¡AY·íªì±À¦ôPFS¥i¯à·|18,³oÓ·|©~©ó¤£§Qªº¦]¯À °O±o2¦~«e³Ìªì¬Ý¨ì¤½¥q¹ï©ó822¹êÅçpµe·í®É´N¹wp³Ì«á¤@Ó¦¬®×µ²§ô«á¦AÆ[¹î2¦~«á¸Ñª¼¡AY·Ó³oÓ±À½×¡A¸Ñª¼®É¶¡·|¦b2016¦~8¤ë¡A³o¼Ë©Ò¦³ªº¹êÅç²Õ/¹ï·Ó²Õ³£¶W¹L2¦~24Ӥ몺Æ[¹î ¦Ü©ó822 PFS, ¥u¯à»¡¥ý«e¯E¤Í̹w¦ôªº¤j©ó18,20³£À³¸Ó¤w¦¨¬°¨Æ¹ê¡A¦ý§Æ±æ¦b6¤ëªÑªF·|®É±i¸³¥i¥H³zÅS"´_µo¤H¼Æ"ªº ¤j·§¡A¨Ò¦p»¡¦pªG¨ì2015¦~5¤ëÁÙ¥¼¹F142ªº¸Ü¡A¨º±N¤ñ¥ý«e¹w¦ô¦b2014¦~12¤ë®É©Ò±À½×ªºPFS¦A¥[¤W5 (¥Ñ©ó¹ï·Ó²ÕPFS¸û§C¡A822 PFS¨Æ¹ê¤W¼W¥[·|¶W¹L5) ¤@´Á¼Ë¥»¼Æ¡B¦¬®×±ø¥ó¡B¹êÅç³]p»P¤G¤T´Á¤£¦P¡A¥B¤@´Á¥Øªº¬O¥H¦w¥þ©ÊÀu¥ý¡AÃĮĨ£ÃҤϦӨ䦸¡A©Ò¥H¦³¥i¯à¬O§ä¤â³N©Î¤ÆÀø«á¤ñ¸û¦nªº¯f±w°µ¬°¹êÅç¤]Ãø»¡¡A¥u¯à»¡¤@´Áµ²ªG«Ü¦n¡APFS 36Ó¤ë¬OÅåÆAªº¡A¦ý¤G¤T´ÁPFS¦pªG·|¬O36ªº¸Ü ¬O§_ªí¥Ü¸Ñª¼®É¶¡»Ýn¦A©µ«á? ¬Æ¦Ün¨ì2017¦~8¤ë? ¤Ï¬M¨ìÃĮħó¦n¡A«onµ¥§ó¤[ªº¥Ù¬Þ... |
|
|
·|û¡G¹Ç§AÅó±ø±ø10135894 µoªí®É¶¡:2015/4/28 ¤U¤È 02:36:19²Ä 236 ½g¦^À³
|
¤µ¤Ñ·Qn§ä¯E¹©ªºâí¡A©Ò¥H¥Î¤F«Ü¦h³]·Q¡AÃÒ©ú¬O§_§ë¸ê¿ù»~·|¿é¨ì²æ¿Ç¡A¦Ó¥B¥Î¤wª¾°T®§¨Ó±ÀºV 1.822 ¨ÅÀù¹êÅç¼Æ¾Ú¤£²z·Q«Å§i¥¢±Ñ ÁÙ¬On¬ÝPFS, °²¦p¹ï·Ó²Õ§´µ½ªvÀø¥i¥H¦³°ª¹F10Ӥ몺PFS, ¦]¬°¨ì2014¦~12¤ë¤´µM¥¼¹F142¤H´_µo±ø¥ó ºâ¥X¨Ó822¥²¶·nPFS>18¤~¯àº¡¨¬³oÓ±ø¥ó ¦Ü©óPÈ¡A¥ý«e¤w¸g¦³¤j¤j»¡¹L¡APFS°÷¦n¡APȦ۵M·|<0.05 --> 822¨ÅÀùÁ{§Éµ²ªG·¥¤j¥i¯à¬O¬ð¯}©ÊÀøªk¥Ó½ÐÃÄÃÒ 2.822 §Z±_Àù¼Æ¾Ú¤£²z·Q«Å§i¥¢±Ñ ³oӥѩ󥼦³©ú½T¼Æ¾ÚµLªk±ÀºV¡A¤£¹L¥Ñ©ó§Z±_Àù´c©Ê«¤j¡A´NºâPFS 6 VS PFS 4¡A¤]·|¼W¥[50% PFS §Y¨ÏPFS, OS³£¥¼¦³ÅãµÛ®t²§¡A¥u¯à»¡822¤£¾A¥Î©ó§Z±_Àù¡A¸ò822¨ÅÀù¼vÅT¤ñ°_¨Ó¬O¤p±o¦h¡A¤£·|³y¦¨ªÑ»ù«¤j¼vÅT Àù¯g¾÷Âà´_Âø¡A¥úGlobal HÁöµMµo²{¦b16ºØÀù¯g¡A¦ý¾AÀ³¦³®ÉÔnÁ{§É¤~·|ª¾¹D¦¨®Ä¡A¤]¨Ã«D¤@©w³£¦³®Ä³o¤]¬O¨Æ¹ê 3.833/858/868/888 ³o¨Ç¬O©µÄò822¦¨¥\¦A³Ð°ª®pªº±µ¯Z¤H¡A822n¥ý¦¨¥\¡A¤£µM³o¨Ç´NÅã±o¦¨¥\¾÷·|¤j¤j°§C ª©¤W¦³¤H¬ÝªÅ¬O«Ü¦ÛµMªº¡A´N¸ò¥j¤H»{¬°¦a²y¬O¦t©z¤¤¤ß¤@¼Ë¡A¥H«e¥xÆW¨S¦³·sÃĦ¨¥\¡A¤£¥Nªí¥H«á¤£·|¦³¡A¯E¹©¬O«Ü¥i¯à¦¨¥\ªº¡C»¡¼Æ¾Ú¤£¼ÖÆ[ªº¤H®Ú¥»´N¬O½M§è¡A³s¤½¥q¦b¸Ñª¼«e³£µL±q±oª¾ªº¨Æ±¡¡A¾aÂIÃö«Y´N¯à®³¨ì¡A¯º¦º¤H¤F ¦³¤H¦Ñ»¡ªL¤j¤á½æ¦h¤Ö±i¡A§Ú«Ü¯Ç´e¡AªL¤j¤á¬O¦³´X¸U±i¦n½æ¶Ü? ¦pªG¨C¤Ñ½æ¦A¦h¤]¦½æ¥ú¤F ¬Q¤Ñº¦°±ªO¤£»°§Ö½æ¦h¤@ÂI(¥X1000±iº¦°±»ù)Ãø¨ìn¤µ¤Ñµy·L½æ¤@ÂI´N¶^10¤¸³o¼Ë¸ò¦Û¤v¶r²¼¹L¤£¥h¶Ü? ´²¤á´N¬O¤£°÷¹Îµ²¡A¤@¦³¤H¶Ã©ñ®ø®§´N°l°ª±þ§C¡AÃø©Ç³£ÁȤ£¤F¿ú¡A°¾°¾¦³¤HÁÙ¸g±`©ñ®ø®§¥ø¹ÏÀ~§ë¸ê¤H¡A©~¤ß¦ó¦b? |
|
|
·|û¡G¹Ç§AÅó±ø±ø10135894 µoªí®É¶¡:2015/4/27 ¤U¤È 01:40:42²Ä 235 ½g¦^À³
|
¸UÂI¦æ±¡ ¥Í§Þ¤£¯Ê®u¡I¯E¹©±a¶¤ ¤WÂd¥Í§Þ¤jº¦3.6% 2015/04/27 12:40 ¹d¦ëºô °OªÌJíõ¤å ¥x¥_ ¹d¦ëºô°OªÌJíõ¤å ¥x¥_ ÝÀ¹H15¦~¡A¥xªÑ¤µ¤Ñ½L¤¤²×©ó¤S¨£¨ì¸UÂI¡A³oªi¥Ñ¥~¸ê±À¤Éªº¦æ±¡¡A¤º¸ê¨Ó¤£¤Î°Ñ»P¡A¤£¹L¤µ¤Ñ½L¤¤¡A³Qµø¬°¤º¸ê«ü¼Ðªº¥Í§Þ±Ú¸s¡A¤µ¤Ñ¤]¸s°_±j§ð¡A¥Ñ·sÃĪѤý¯E¹© (4174) ±a¶¤¡A¤£¶È¥x·LÅé (4152) ¡B°ò¨È (3176) ³£½Ä¤Wº¦°±¡AÂå¬ü±Ú¸s¤j¦¿ (8436) ¡BÂ`¨È (4138) ¤]½Ä¤Wº¦°±¡A¤WÂd¥Í§ÞªÑ½L¤¤¤@«×¤jº¦3.6%¡A¤@¦R´e®ð¡I ¤µ¤Ñ½L¤¤¥Í§ÞªÑ¦@¦³¯E¹©¡B¥x·LÅé¡B°ò¨È¡B¤j¦¿¡BÂ`¨È¡B¦X¥@ (1781) µ¥¦hÀɽĤWº¦°±¡A¥BÀH¯E¹©±a¶¤¡AªF¬v (4105) ¡BÑÔ¼w (4123) ÂùÂùº¦´T¤]³£ªñ5%¡C ªk¤H«ü¥X¡A¥Ñ©ó¨º´µ¹F§J¥Í§Þ«ü¼Æ«ùÄòµn°ª¡A¥xªÑ¥Í§Þ±Ú¸s³oªi¨«¶Õ¡A©úÅ㸨«á¡A¤º¸ê·Qn·m·f³oªi¸UÂI¦æ±¡¡A¤Ï¦Ó¡u¨Sº¦¨ì¡vªº¥Í±Ú¸s¡A¤µ¤Ñ¬Ý¨Ó¡A¦¨¬°¤º¸ê«æ¦£·m¶iªº¼Ðªº¤§¤@¡C ªk¤Hªí¥Ü¡A¥Í§Þ±Ú¸s¤¤¡A·sÃıڸs쥻´N¤£¬Ý¥»¯q¤ñ¡A¦ý¥i¯d·NÂå§÷¡B»sÃĵ¥¡A¦³³¡¤Àº©u·~ÁZ³£¦³¤£¿ùªºªí²{¡A °]³ø¤]±NÀu©ó¹w´Á¡C |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2015/4/27 ¤W¤È 11:18:01²Ä 234 ½g¦^À³
|
¹Ç§AÅó±ø±ø¤j 1·PÁ§Aªº¸Ñ´b,§A»¡ªº«Ü¦n:¦pªG¤ß¹Ò¦p¼B³Æ¡A¥u¯àºâ¬O¤¤¦N¡A¦ý¬O¦pªG¦pªªµ£¯ë©ÉµM¦Û±o¥±`¤ß¬Ý¸Ñª¼¡A¹ê¬°¤j¦N 2±i¸³¦b³X°Ý¤¤´£¨ì¬ü°ê¥Í§Þ¤½¥q¬ãµoªºÃĪ«,·í¤T´Á¦¨¥\,¼Æ¾Ú¤½§i, ¸Ó¤½¥qÁ`¥«È·|¦³50~100»õ¬üª÷,§Ú·Q³o¥u¬O¤@ÁûÃÄ,Ãþ±À¨ìOBI822¬O«ü¨ÅÀùÃÄ,(¤£¥]§Z±_Àù,¤]¤£¥]¬A¨ÅÀù ¼Ú ¤é Áú ¤¤«n¬ü¬w¦æ¾P¦X§@±ÂÅvª÷ªº¦¬¤J,§ó¤£¥]¬AOBI833,OBI888¤ÎÁÞ´¹¤ù¤Î¦×¬r±ìµß¯Àªº»ùÈ)¤]´N¬OÁ`¥«È·|ÀH³o«áÄò²£«~¬ãµo¦¨¥\,¦æ¾P¦X§@±ÂÅvª÷ªº¦¬¤J¤Î¤W¥««áªº¾P°âÃB²£¥ÍªºÀò§Q¤£Â_¤W½ÕÁ`¥«È |
|
|
·|û¡G¯E§J10140302 µoªí®É¶¡:2015/4/27 ¤W¤È 11:00:42²Ä 233 ½g¦^À³
|
³s°ò¨È³£º¦°±.¯E¹©¥u¬O¤Ï¼u¦Ó¤w.³Ì¦h¤Ï¼u¨ì360.¤§«á´N·|¦A¶^¤F |
|
|
·|û¡G¹Ç§AÅó±ø±ø10135894 µoªí®É¶¡:2015/4/27 ¤W¤È 10:47:07²Ä 232 ½g¦^À³
|
¸É¥RÆFÅÒ¸ÑÅÒ¥X³B: http://mo202pingsang.blogspot.tw/2014/10/blog-post_14.html |
|
|
·|û¡G¹Ç§AÅó±ø±ø10135894 µoªí®É¶¡:2015/4/27 ¤W¤È 10:43:23²Ä 231 ½g¦^À³
|
µu½u¡G¯E¹©¤µ¤Ñ(4/27)¤~1300±i¶q´Nº¦°±Âꦺ¡A¤WÂd«á©âÅÒ¤Þ¨ÓÄw½Xâ¶Ã¤wµM¨I¾ý®ø¤Æ¬pºÉ¡A³Ñ¤UÄ@·N¤¤ªø´Á«ù¦³¯E¤Í©~¦h ©e¶R¤w¸g¶W¹L1000±i¡A¥B320¤¸ªº¤jW©³¥´±o°÷º}«G¡A¬Ý¨Ó³sÃÒ©Òµ|³±¼vªº³Ì¶Â·tªº®É¥ú¤wµMµ²§ô ®ü¤j¤á·Q½æ¥i¤w¥X1000±iº¦°±»ù¡A¥i¬O¨S¦³¥X²{¡Aªí¥Ü®ü¤j¤án¤£¥Xªº®t¤£¦h¤F¡An¤£´N¬O·Ç³Æ¤Ï¤â°µ¦h ¯Q¾~¦b«ç»ò¥s¶Â©]¹L«á¥Õ¤ÑÁÙ¬O²×·|¨Ó¨ì ¤¤ªø½u¡GÀHµÛ¸Ñª¼¼Æ¾ÚÁÍ©ó©ú®Ô¼ÖÆ[¡AªÑ»ù±ý¤p¤£©ö¡A´N¦p±i¸³»¡ªº·Ç³Æ°_¸§a ¥xÁÞ¤j±z»¡Y¤T´Á¦¨¥\50~100»õ¬üª÷¥«È¡A¥H17»õªÑ¥»¨Ó¬Ý¡A¨CªÑÈ1000~2000¤¸¥ª¥k ¨ä¹ê³oÀ³¸Ó¬O¤@¯ëÃÄ¡AÁÙ¤£¬O¤jÃĪº»ùÈ¡A¤jÃÄ¥i¯à¼Æ¿¬Æ¦Ü¼Æ¤Q¿©ó¦¹ ¨Ò¦pHerceptin¤@¦~´N¥i¥H½æ60»õ¬üª÷¡A©Ò¥H³oÁûÃĦܤÖÈ600»õ¬üª÷~~ ¥ý«e»¡ªº"§ë¸ê¤£¬O¤£¦^³ø¡A¥u¬O®É¶¡ÁÙ¨S¨ì"¡A ¥«³õ¤W´N¬O«Ü¦³½ì¡A310/320¤j®a®£·W¨S¤H´±¶R¡A¤µ¤Ñ345.5º¦°±ÁÙ¦³1000¦h±i·Q¶R Ãø©Ç´²¤á°l°ª±þ§C·|½ß±o«ÜºG¡A¦pªG5¤ë¨ì400«á¬O§_¤Sn§â¤â¤¤«ùªÑ½æ¥ú¥ú? ¥i¯àÁȤF¤@ÂI«Ü²n¡A¦ý¬OÂ÷§ÚÌ»{ª¾ªº¯u¹ê»ùÈÁÙ®tªº»·¡C «Ü¦¥H«e»¡¦~©³¬Ý800,ÁöµM¥i¥H»¡¬O"«H¤f¶}ªe"¡A¦ý¬O¬ÝµÛ¸Ñª¼®É¶¡«Å¥¬¡A¬O§_ªï¨Ó³oÓ¥i¯à©ÊªºÀÆ¥ú? »¡¹ê¸Ü´Nºâ800§Ú¤]¤£·|½æ¡AÄ~Äò¹Ç§AÅó±ø±ø¡A¤£¹L¦pªG¤W800,·Q°_¨Ó¤]¬O¥ó«Ü²n§Öªº¨Æ ·|¬O¥Õ¤é¹Ú¡A¯B¶³¤Û¼v¡AÃ褤¤ë¤ô¤¤ªá³£¦n¡A¤j®aªº¹Ú·Q·|¤£·|¹ê²{¡A®É¶¡·|ÃÒ©úªº°Õ 4174, 4+1+7+4=16 ²Ä¤Q¤»籖 ¤¤¦N ¥eÅç¥j¤H¡G¬Ó¨û¹J¤ôÃè ¡e籖¤å¡f ¤ÑÃä¾~I¤i¶§¦^¡AÃ÷¥~¨àµ£¸óÃ}¨Ó¡C 羗²ÃÀW§jÁn¤Á¦Õ¡AµuªøµÄ½Õ¼Ö¦ó«v¡I ¡e¥eÅç¥j¤H¡f ¥eÅç¥j¤H¡A¤@¥»§@¡uªªµ£¸óÃ}¦^Âk¡v¡C¸óÃ}§YÃMµÛ¤p¤û¡F¦^Âk§Y¦^®a¡C³oÁö¬OÅÒ¤å©Ò¼gªº¤º®e¡A¦ý¤£©y¦]¦¹¦Ó§âìÃD§ï¤F¡C¥h±¼¤F¥j¤H¡A©Ò¿×¡u¥eÅç¥j¤H¡v«KµL·N¸q¡C¥»¤å¤´¥ÎìÃD§@¸Ñ¡C ¬Ó¨û¡A§Y¼B³Æ¡A¦]¬°¥L¬O¦èº~´º«Ò²Ä¤EÓ¨à¤l¤¤¤s¹t¤ý¼B³Óªº«á¥N¡A©Ò¥H·í®Éªº¤H«K´LºÙ¥L¬°¼B¬Ó¨û¡C¤ôÃè¡A§Y¥q°¨À²¡A¥L¾Õªø¬Û³N¡A¦³ª¾¤H¤§©ú¡A¤HºÙ¤ôÃè¥ý¥Í¡C¡m¤T°êºt¸q¡n»¡¡G¼B³Æ¦bÀȷ˪þªñÃM°¨¡A¨Ó¨ì¤ôÃè¤s²ø¡C¥LÅ¥»¡¹L¤ôÃè¥ý¥Íªº¤j¦W¡A©ó¬O·QÁܽХL¥X¤s¬Û§U¡C¤ôÃè¥ý¥Í°û©Ú¥L¡A¦ý«o«üÂI¥L»¡¡G¡u¥ñÀs¡B»ñÂú¤G¤H±o¤@¡A¥i¦w¤Ñ¤U¡C¡v¥ñÀs¬O½Ñ¸¯«G¡A»ñÂú¬OÃe²Î¡C¼B³Æ©ó¬OÂà¦Ó¥h´M§ä¤G¤H¡C«á¨Ó¤G¤H³£§ä¨ì¤F¡A¤G¤H¦b¼B³Æ¯u¸ÛªºÁܽФU¡A³£µªÀ³¥X¤s¡C¦ýÃe²Î¤£¤[«K©ó¡u¸¨»ñ©Y¡v®îÃø¡A¥u³Ñ¤U½Ñ¸¯«G¦Ó¤w¡C¼B³Æ±o½Ñ¸¯«G¤§§U¡AªF³s®]§d¡A¥_§Ü±äÃQ¡A³Ì«á¦b¥|¤t¦¨¥ß¸¾º~¡A§Î¦¨¤T°ê¹©¥ßªº¬Fªv§½±¡C ¡e¸ѡf ¤é¸¨¤s©£®É³ï¡A¤ÑÃ䤧¾~ÄNÂk±_¡AÜñ¤Wªª¤ûµ£¤l¤SÃM¤û¦ÓÂk®a¡A§j±o¦Ë²Ã¤§Án¥Rº¡¦Õ¡C¦¹µ£¤l¥ç¬Æ§Ö¼Ö¤]¡C¦¹籖¦³§Ö¼Ö¤§·N¡A«h¤Z¨Æ¥ÃµLê¡A¤£¥Î¼~¤ß¨o¡C ¡e·s¸Ñ¡f ¸Ѧ³¨âÓ¥Dnªº¯ÊÂI¡G¤@¡B¸g±`¤£¸Ñ¥eÅç¥j¤H¡A¨Ï¥j¤HÄaªÅ¦b¨º¸Ì¡A¤£ª¾¦p¦ó¬O¦n¡F¤G¡B§â¥eÅç¥j¤H¬Ý¦¨¬O¥t¤@Ó¥j¤H¡A¦p±N¤ý«k»¡¦¨¤ý¿ª¤§¡]²Ä¤»ÅÒ¡^¡B³³²W©ú»~§@ĬªF©Y¡]²Ä¤Q¥|ÅÒ¡^µ¥¡A±`¾x¥X¯º¸Ü¡C³oªKÅҩҥǪº¤ò¯f´N¬O²Ä¤@ÂI¡CÅÒ¤å©Ò¼gªº¡A¬Oªªµ£¦b³Ä±ß®É¤À¡AÃM¦b¤ûI¤W¦¬¤u¦^®aªº´r§Ö¤ß±¡¡A¸ò¼B¬Ó¨û¤S¦³¦óÃöÁp©O¡H¸Ѵ£³£¨S´£¡C ¼B³Æ·í¦~³Q±ä¾Þ°l±þ¡A«n¤U°k¤`¡A¤£ª¾¦p¦ó¬O¦n¡C©¯±oÃö¶³ªø¡B±i¸¨â¦ìµ²«ô¥S§Ìªº¦P¤ß¦X¤O¡Aæí°}¸}¡A¤~±o¥He©µ¡C¦ý³o¼Ë²×¤£¬O¿ìªk¡A¥L«D±`»Ýn§ó¦hªº´©§U¡C³o®ÉÔ¡A¥Lªº¤ßºA¬O·K´a¤£¦wªº¡C¦ÓÅÒ¤å©Ò¼gªº¡A«o¬OÀu¶¢ªº¡A§Ö¼Öªº¥Á¶¡¥Í¬¡¡A¸ò¼B³Æªº§xW¾D¹J§Î¦¨·¥¤jªº¹ï¤ñ¡C¼B³Æ¹J¨ì¤ôÃè¥ý¥Í¡A¥i»¡¬O®p°j¸ôÂà¡A¬h·tªá©ú¡A±o¨ì¤F¤@½u§Æ±æ¡C¦]¦¹¡A§Ú̱o¨ìªº±Ò¥Ü¬O¡G³oªKÅÒ§i»|§ÚÌ¡A¤£n¦Û¥H¬°¬O¡F¦bWÃø¤¤§ó»Ýn¦h¦V¥L¤H½Ð¯q¡A´¼¼zªº±Òµo¤ñª÷¿úªº´©§U§ó«n¡C¨S¦³´¼¼z¡A´Nºâ¾Ö¦³Åv¤O¤]²×±N¥¢¥h¡F¦Ó´¼¼z«oµL¤H¯à¨ú¥N¡C ¥Ñ¼B³Æªº§x¹y»Pªªµ£ªº±y¶¢¬Û¹ï·Ó¨Ó¬Ý¡AµL±ýµL¨D¡A¦^Âk¦ÛµM¡A¤~¬O¡u¼Ö¦ó«v¡vªº¥Í¬¡¹Ò¬É¡C²{¥N¤H»¡¡G¡u¥¤Z´N¬O©¯ºÖ¡C¡v¦b¶Ã¥@¤¤§ó¯àÅé·|¨ìºç¤¤¹D²z¡CÅÒ¬O¤¤¦N¡A¹ï¼B³Æ¨Ó»¡¡A§x¤¤¨D¦w¦Ó±o¦w¡A©TµM¬O¤¤¦N¡F¹ïªªµ£¨Ó»¡¡AµL¦wµL¤£¦w¡Aª¾¨¬±`¼Ö¡A©y§@¤j¦N½×¡C ¦U¦ì¯E¤Í¦pªG¤ß¹Ò¦p¼B³Æ¡A¥u¯àºâ¬O¤¤¦N¡A¦ý¬O¦pªG¦pªªµ£¯ë©ÉµM¦Û±o¥±`¤ß¬Ý¸Ñª¼¡A¹ê¬°¤j¦N~~ ¦@«j¤§~~ |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2015/4/26 ¤U¤È 10:39:55²Ä 230 ½g¦^À³
|
¶Â´ËªL«á±ªº±mi ¥H«e«Ü¦h¯E¤Í¦b°Q½×822¤T´ÁÁ{§É¦¨¥\,¼ÆÈ¥X¨Ó«á¤½¥q¦X²zªÑ»ùÀ³¸Ó¦h¤Ö? ²³»¡¯É¯Æ,¯Ê¥F¼Ð·Ç,ª½¨ì¬Ý§¹±i¸³°Ó·~©P¥Z±M³X«á,¤ß¤¤¤~¦³¤@Ó©ú½Tµª®×:¤@Ó¶i¤J¤T´ÁÁ{§Éªº¤j«¬ÃÄ,³æ¤@²£«~¦~À禬¼ç¤O¶W¹L¤Q»õ¬ü¤¸¡A¤T´ÁÁ{§É¦¨¥\,¼ÆÈ¥X¨Ó¥H«á¡A¤½¥qÁ`¥«ÈÀ³¸Ó¬O5¨ì10ÓBillion¡]10»õ¬ü¤¸¡^¡A¤]´N¬O50»õ¬ü¤¸¨ì100»õ¬ü¤¸¤§¶¡,§Ú©l²×¬Û«H¤@¦ì¦b¬ü°ê¥Í§Þ¬É30¦h¦~,¬Ý¹LµL¼Æ¥Í§Þ¤½¥q¬ãµo¦¨¥\ªºÃĪ«,¥Lªºµû¦ô¬Oȱo«H¿à»P«ÈÆ[ªº ¹Ç§AÅó±ø±ø¤j,§A¥H«e¦³¹w´ú¤½¥q¦X²zªÑ»ù,·Q½Ð±ÐÁ`¥«È50»õ¬ü¤¸¨ì100»õ¬ü¤¸¤§¶¡´«ºâªÑ»ù¬O¦h¤Ö? ±q±i¸³°Ó·~©P¥Z±M³Xªº½Í¸Ü§PÂ_,³Q§A²q¤¤ªº¾÷²v»á°ª |
|
|
·|û¡G¸U¤¸10031351 µoªí®É¶¡:2015/4/26 ¤U¤È 05:28:31²Ä 229 ½g¦^À³
|
¯E¹© À³¸Ó¬O¥Ø«e°ê¤º³Ì¦³§Æ±æªº¥Í§ÞªÑ²¼¤F ¤W¥««e«á ¦³³\¦h¬ã¨s³ø§i ³£«ü¥X¨ä¥¼¨Ó©Ê¥i´Á ¥²´Iºô³o¸Ì¤]¦³³\¦h±M·~ªº°Q½× §Ú¤]»á»{¦P ¦ý¨º¨Ç¤j¤jªº¦¨¥»³£»á§C À³¸Ó³£¤£¨ì¨â¦Ê ¬Æ¦Ü¤@¦Ê³£¤£¨ì ©Ò¥H¥LÌ¥i¥Hªø©ê ¤£©Èµu¤¤´Áªº¾_Àú ¸ò¥L¤@·i ²{¦b¥LªºªÑ»ù¬O§C§í©Î°ª(µu¤¤´Á¡^¡H ªø´Á¶RÂI¨ì¤F¶Ü¡H ȱo²`«ä ....¥x±¤WªºªÑ¤ý ¤]³£´¿¾ú¸g¤j´T«×ªº×¥¿ ¦Ó²{¤µ ³\¦h¥Í§ÞªÑ³£×¥¿¤@¤j¬q¤F °ß¦³¯E¹©ºâ¬O¬Û¹ï±j¶Õ ¡K.¦bMobile 01 ¦³¤@¨Ç¤£¤@¼ËªºÁnµ»P°Q½× ¥i¥H°Ñ¦Ò¤@¤U³á |
|
|
·|û¡G= =10140302 µoªí®É¶¡:2015/4/26 ¤U¤È 02:08:26²Ä 228 ½g¦^À³
|
¤p°g½k¤j§A»¡ªº¹ï.³o¸Ì¤Ó¦h¤H¦b¥X³f.¦nÀI§A¨S¤W·í |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2015/4/24 ¤U¤È 05:00:03²Ä 227 ½g¦^À³
|
¤p°g½k¤j Æ[¥@µµÐÂĤ£§Æ±æªB¤Íªº¶ý¶ý°µµu½u,·Qµu®É¶¡´Nn¤W¤dÀò§Q,Æ[¥@µµÐÂÄ·íµM¤£·|»{¦P,©Ò¥H·|³s»¡¤¦¸¤£¥i¤£¥i, ¦]¬°¨S¦³¸g¹L·Î¼õ´Nì§Q,¤£²Å¦X¦t©zªº°ò¥»ì²z,«Ü¦h¤j¤jÌ»{¯u¾Ç²ß,¨¯W¬ã¨s,ªø´Á«ù¦³ªÌÁöµM¦³¦^ÀÉ130¤¸¤]¯àÀò§Q1¨ì3¿¬O¦]¬°¥L¦oÌ@¤ßµ¥«Ý,¸g¾ú¤F¤@µf´H¹ý°©,¦³¥¢¤~¦³±o,¥i¥H¦A½ÐªB¤Íªº¶ý¶ý¸òÆ[¥@µµÐÂÄ»¡§Ú·Qªø´Á«ù¦³¯E¹©,¦p¦³Àò§Q·|¦^õX®z¶Õ±Ú¸s,¦AÂYªM¬Ý¬Ý |
|
|
·|û¡G¤p°g½k10137614 µoªí®É¶¡:2015/4/24 ¤U¤È 12:36:37²Ä 226 ½g¦^À³
|
¸ò§A»¡¤@¥ó¨Æ ¤WÂd«e§ÚªB¤Íªº¶ý¶ý쥻¤]Å夣¦í»¤´b·Q¶R¤@¤ä¯E¹© »¡·|¤W¬Ý1000. ¥L̼ӤW¦³¨Ñ©^¤@´LÆ[¥@µµÐÂÄ ¦o¥Î»éªM³s5ªM³£¨S¦³ªM ¥s¦o¤£n¶R ¥¦´N¨S¶R¸ú¹L¤@§T. |
|
|
·|û¡Gdennislu10137962 µoªí®É¶¡:2015/4/24 ¤W¤È 10:53:16²Ä 225 ½g¦^À³
|
«¢«¢¡A§Ú¬Ý¨ì¤FÂÃÀY¸Ö ¯E¹©¦³¾÷·|¤W¬Ý¸U¤¸ªÑ»ù ¡A¤j®a¦Û¦æ·Q¹³ ÅÒ¤ý ¨D±oÅÒ¤ý¦Ê¨Æ¨} ¸U¨Æ¦p·N¤j¦N©÷ ©y¥[¤O§@¦æ¤è«K ¥i«OºÖ¹Ø¥Ã¦w±d ¨D ¸U ©y ¥i ¯E¹©¥[ªo°Õ!!! |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2015/4/24 ¤W¤È 10:21:07²Ä 224 ½g¦^À³
|
¦³Ãö lights up on a PET scan PET scans see metabolic activity not cancer. Cancer tends to be more active thus it "lights up" on a PET scan but there are a number of other things that light up just like cancer. Infections and healing wounds are just a couple of things that light up on PET scans. The Dr at MD Anderson is right to get a biopsy to determine if it really is cancer or not. Àù¯g,·P¬V ,²¬Â¡ªº¶Ë²ª·| lights up on a PET scan ,¦pªG¥H«e´N¦³µo²{ ,¥Ø«e¨S¦³ÅܤÆ,¤Á¤ùÀˬd´N«Ü«n, ¤Á¤ù¬O³±©Ê,´N¤£¬OÀù¯g¤]µL´c¤Æ²{¶H |
|
|
·|û¡G¹Ç§AÅó±ø±ø10135894 µoªí®É¶¡:2015/4/24 ¤W¤È 09:29:36²Ä 223 ½g¦^À³
|
¥xÁÞ¤j¡A±z¯u¬O¤Ó¼F®`¤F¡Aª½±µÀ°¤p§Ì¸Ñ¨M¤F³oÓºÃ°Ý ¾Ç¾ú¥u¬Oªí±ªº¡A§Î©ó¥~ªº¡A¯u¥¿¤º¦b¥\¤Ò¤~¬O¼F®` ±i¸³¤]¤£¬O¥x²M¥æ¡A¤Ï¦Ó¦¨´N»·°ª©óµ´¤j¦h¼Æ¥x²M¥æ¡A§ó¬O¯E¤Í̤ߤ¤³Ì¨Îªº´x²ë¤â 6¹êÅç²ÕY¦³5%,10%,15%,20%¹ï822¨S¦³¤ÏÀ³®É¹ï¸Ñª¼®ÉÔPFS, P value¬O·|²£¥Í«ç¼Ëªº¼vÅT? ¦pªG¥À¸sÅé¯u¥¿®ÄªG¨S¦³®t²§¡A¬ã¨sµ²ªGªºp ȱNÀH¾÷¥X²{¦b0 ¨ì1 ¤§¶¡¡A¸ò¼Ë¥»¼Æ¤j¤p¨S¦³Ãö«Y¡C ¥i¬O¥un¥À¸sÅ骺¯u¥¿®ÄªG¦³®t²§¡A¬ã¨sµ²ªGªºpÈ´N·|ÀHµÛ¬ã¨s¼Ë¥»¼Æ¼W¥[¦Ó¶V¨Ó¶V¤p A ·í822µL®Ä®É¤~·|¼vÅTPFS »PP value, ´Nºâ¨â²Õ´c¤Æ¤H¼Æ¬Û¦P,P value¤]·|¤p©ó0.001 B ·í¹ï822¨S¦³¤ÏÀ³ªº¤ñ²v¶V°ª,¹êÅç²Õ´c¤Æ¤H¼Æ¤Ó¤Ö®É¸Ñª¼¹ïPFS´N·|¦³¼vÅT C PFS ¦n»P¤£¦nn¬Ý´c¤ÆªÌ¬O§_¨Ó¦Û¦´Á¦¬®×ªº¨º¤@§å¨ü¸Õ ¨Ãµû¦ô¹ï822¨S¦³¤ÏÀ³ªº¤ñ²v ¦pªG¦³10%¹ï822¨S¦³¤ÏÀ³ p23¤H ¹êÅç²Õ¦b´c¤Æ¤H¼Æ¦b46¤Hªþªñ®É¸Ñª¼¦³·ÀI ¦pªG¦³15%¹ï822¨S¦³¤ÏÀ³ p35¤H ¹êÅç²Õ¦b´c¤Æ¤H¼Æ¦b70¤Hªþªñ®É¸Ñª¼¦³·ÀI ¦pªG¦³20%¹ï822¨S¦³¤ÏÀ³ p47¤H ¹êÅç²Õ¦b´c¤Æ¤H¼Æ¦b94¤Hªþªñ®É¸Ñª¼¦³·ÀI(20$ ¤ñ²v»P¨Æ¹ê¤£²ÅÀ³¥i±Æ°£) »{¦P¤p©_¤j¥ý«e©Ò¨¥:¹êÅç²Õ¦b´c¤Æ¤H¼Æ85¦Ü116¤H®É¸Ñª¼¸û¦w¥þ --> ¦pªG¹êÅç²Õ¦b´c¤Æ¤H¼Æ85¦Ü116¤H®É¸Ñª¼¸û¦w¥þ,¤p§Ì¹w¦ôPFS 24®É·|¸¨¦b¤U¥b¦~¡APFS 30®É·|¦b©ú¦~ªì PFS 36¥i¯àn¨ì©ú¦~¤¤¤F |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2015/4/23 ¤U¤È 06:02:09²Ä 222 ½g¦^À³
|
¹Ç§AÅó±ø±ø¤j 1§A»¡ªº¯u¦n,§ë¸ê¯E¹©¤£¦ý¥i¥H°Ñ»P¥xÆW¥Í§Þ²£·~ªº±U°_¡A§ó«nªº¬OY¦³´Â¤@¤é¦¨¬°¥xÆW¤§¥ú®É¡A¤£¦ý¥i¥H³yºÖÀù¥½±wªÌµL¼Æ,¦U¦ì©Ò¾Ö¦³ªº§ë¸ê¦^³øÂ׺Өì´X¥GµLªk·Q¹³ªº¦a¨B¡C 2§Ú¥H«eÅ¥¹L±i¸³ºtÁ¿:´¿»¡¹L¬ü°ê¥Í§ÞªÑ±qIPO¨ì²{¦b«Ü¦h¦n¤½¥q¦Ê¿¤d¿ªºº¦ 3«Ü¦h¯E¤Í¤£½æªºì¦]¬O¤£·Q¥uÁȤ@¤p¬q,¬ü°êNBI¥Í§Þ«ü¼Æ¤µ¦~§ó³Ð¾ú¥v·s°ª,¥xÆW¤~¨«2-3¦~¦hÀY,¦pªG¯uªº¦p¬ü°ê¤@¼Ëµo®i°_¨Ó,¦n¥ú´º·|¶W¹L30¦~ (120¦hÁûÃĦb¬ãµo¤¤ ¨ä¤¤20¦hÁû¶i¤J¤T´Á) 4¥H«e¦b¶K§¹¤å«á±`·|¥[ª`ĵ»y,¦]¬°¨CÓ¤H¤À¨É³£¤£¥i¯à¬O§¹¬üµL¯Ê,¨CÓ¤H¬Ýªº¨¤«×¤£¦P,ÂsÄýºô¶ªº§ë¸ê¤HÀ³¸Ón¸g¹L a¹LÂob§l¦¬c¦Aºë¶iªº¹Lµ{,¥H§@¬°§ë¸ê°Ñ¦Ò,²¦³º¥u¦³¦Û¤v¤~¯à¨M©w§ë¸ê¦æ¬°,¦b°µ¦n·ÀIºÞ²z¤U²z©Ê§ë¸ê³Ð³y³Ì¤jÀò§Q 5 ¨C¦ì¤j¤jµL¨pªº¤À¨É,¨C¤H±q¬Y¤@Ó¨¤«×¤Á´N¯à«÷¥X±µªñ§¹¾ãªº¹Ï¹³ 6¹êÅç²ÕY¦³5%,10%,15%,20%¹ï822¨S¦³¤ÏÀ³®É¹ï¸Ñª¼®ÉÔPFS, P value¬O·|²£¥Í«ç¼Ëªº¼vÅT? ¦pªG¥À¸sÅé¯u¥¿®ÄªG¨S¦³®t異¡A¬ã¨sµ²ªGªºp ȱNÀH¾÷¥X²{¦b0 ¨ì1 ¤§¶¡¡A¸ò¼Ë¥»數¤j¤p¨S¦³Ãö«Y¡C ¥i¬O¥un¥À¸sÅ骺¯u¥¿®ÄªG¦³®t異¡A¬ã¨sµ²ªGªºpÈ´N·|ÀHµÛ¬ã¨s¼Ë¥»數¼W¥[¦Ó¶V來¶V¤p A ·í822µL®Ä®É¤~·|¼vÅTPFS »PP value, ´Nºâ¨â²Õ´c¤Æ¤H¼Æ¬Û¦P,P value¤]·|¤p©ó0.001 B ·í¹ï822¨S¦³¤ÏÀ³ªº¤ñ²v¶V°ª,¹êÅç²Õ´c¤Æ¤H¼Æ¤Ó¤Ö®É¸Ñª¼¹ïPFS´N·|¦³¼vÅT C PFS ¦n»P¤£¦nn¬Ý´c¤ÆªÌ¬O§_¨Ó¦Û¦´Á¦¬®×ªº¨º¤@§å¨ü¸Õ ¨Ãµû¦ô¹ï822¨S¦³¤ÏÀ³ªº¤ñ²v ¦pªG¦³10%¹ï822¨S¦³¤ÏÀ³ p23¤H ¹êÅç²Õ¦b´c¤Æ¤H¼Æ¦b46¤Hªþªñ®É¸Ñª¼¦³·ÀI ¦pªG¦³15%¹ï822¨S¦³¤ÏÀ³ p35¤H ¹êÅç²Õ¦b´c¤Æ¤H¼Æ¦b70¤Hªþªñ®É¸Ñª¼¦³·ÀI ¦pªG¦³20%¹ï822¨S¦³¤ÏÀ³ p47¤H ¹êÅç²Õ¦b´c¤Æ¤H¼Æ¦b94¤Hªþªñ®É¸Ñª¼¦³·ÀI(20$ ¤ñ²v»P¨Æ¹ê¤£²ÅÀ³¥i±Æ°£) »{¦P¤p©_¤j¥ý«e©Ò¨¥:¹êÅç²Õ¦b´c¤Æ¤H¼Æ85¦Ü116¤H®É¸Ñª¼¸û¦w¥þ 7§Ú¤£¬O²MµØ®Õ¤Í,²M¤j¤£¬O¨CÓ¤H³£¯à¦Ò¤W 8§A¯uªº©â¨ìñ¤ý,ÆgÆgÆg,¦n¹³¦³¬Ý¨ì¦Ê ¤]¦³¬Ý¨ì¸U |
|
|
·|û¡G¹Ç§AÅó±ø±ø10135894 µoªí®É¶¡:2015/4/23 ¤W¤È 10:18:38²Ä 221 ½g¦^À³
|
¥xÁÞ¤j¡A¯u¬O¦r¦r¯]¿Y¡A¥y¥y½e¨¥....Åsªº4 (wonderful) ²M¤j®Õ°V¬°¡G¡§¦Û±j¤£®§¡A«p¼w¸üª«"¡A«¢«¢³o§Úª¾¹D¡A¥H«e©À®Ñªº®ÉÔ¤j§°ó(¦¨¥\´ò¯`)¥~Àð´N¦³ÃD³o¤K¦r ¥u¬O·í®É³£¨S¦³¥J²Ó¥h·Q¨ä¤¤ªº¹D²z¡A±z¤]¬O®Õ¤Í¶Ü? ¦pªG¤]¬O»¡¤£©w¥i¥H¦bª©¤W¶}®Õ¤Í·|¤F ¦^À³¤@¤U¤j¤á¤H®aè¤~ªººÃ°Ý¡A¤p§Ìªº¾Þ§@µ¦²¤ 1.¤p§Ì180¥ª¥kµo²{¯E¹©³oÀɪѲ¼¡Aµy¬°¬ã¨s¤@¤p¬q®É¶¡¡A°_º¦®É¦b200¥XÀY¶}©l¶i³õ 2.ÀHµÛ®É¶¡Á{§É¸ÕÅç¶i®i¡A³°Äò¦b300, 400¦h³£¦³¥[½X 3.©Ò¥H¨ì¥Ø«e§ë¤J¸êª÷¤w¸g¤£¤Ö¡A¥§¡¦¨¥»¤]¤ñ¥Ø«eªÑ»ùÁÙ°ª¡A·N«ä¬O»¡¥»¨Ó§Ú¦³ÁÈ30%,¥Ø«e¤p½ß¤@¤ä°±ªO 4.¦]¬°¶q¤O¦Ó¬°¡A¥Î¥i¥H©Ó¨üªº¸êª÷¡A©Ò¥H´Nºâ½ß¥ú¤F¤]¤£·|¼vÅT¥Íp 5.¤]´¿¦³·Q¹Lµu½u¶i¥X¡A¦ý¬O§Ú¤£¬OªÑ¯«¡AµLªk·Ç½T¹w´úº¦¶^ÁÈ®t»ù¡A¦Ó¥BY¬O¦³«¤j§Q¦h°T®§¦A¥h°l«Ü¥i¯à±o¤£Àv¥¢ (¨Ò¦p822¨ÅÀù¡B§Z±_Àù,833¬ðµM¶i®i©Î¬O»PÂå°|/ÃÄ°Ó/Ãļt¦X§@µ¥) 6.¨S¸Ñª¼¤£·|¬Ý¨ì²×·¥ªÑ»ù(1000+ or 100-)¡A§A¬Ý¨ìªº¬O¯E¹©±q450¶^¨ì320,·|¤£·|¶^¨ì200©Î§ó§C §Ú¬Ý¨ìªº¬O¯E¹©¦³¾÷·|¶W¶VªÑ¤ý¤j²É¥ú3000¤¸¡A10¿ªº§ë¸ê¦^³ø¤§¥i¯à ¿éªº¸Ü³»¦h100%½ß¥ú¥X³õ¡AĹªº¸Ü¥i¯à1000%¦¨¬°¤j´I¯Î¡A©Ò¥HÄ@·NÀqÀqµ¥ 7.³Ì«nªº¬O¬ÝÃĦ¨¥\ªº¥i¯à©Ê¡A¥xÁÞ¤j»¡95%¤j¤j¦¨¥\¡A§Ú¤]³o¼Ë»{¬°©Ò¥H"¹Ç§AÅó±ø±ø" 8.³Ìªñ¦b·Q¬O§_¦³¥i¯à¥Î²Îp³nÅépºâ¹êÅç²ÕY¦³5%,10%,15%,20%¹ï822¨S¦³¤ÏÀ³®É ¹ï¸Ñª¼®ÉÔPFS, P value¬O·|²£¥Í«ç¼Ëªº¼vÅT¡AÁÙ¨S¦³«Ü»{¯u³]p¼Ò«¬¡A¦pªG¦³¿ìªk°µ¥X¨Ó¦A¸ò¤j®a¤À¨É ¦]¬°¤Ó¤[¨S¥Î²Îp³nÅé¡A³£ÁÙ¦^¥hµ¹¦Ñ®v¤F 9.Á`¤§ª©¤Wcliff¤j¡A¥xÁÞ¤j¡A¤p©_¤j¡A²q·Q¤j¡Arabbit¤j¡A£«¬Â¤j¡A¦Ñ¹«¤j¡A¼·¤j¡A¥ò´º¤j.... ³\¦hª×ªêÂÃÀs¦b³o¸ÌµL¨pªº©^ÄmÄ_¶Q¸ê°T¡A¬Ý§AÀ´¦h¤Ö¡AÄ@·N¬Û«H¦h¤Ö§@¬°§ë¸êµ¦²¤ §ë¸ê±q¨Ó´N¤£¬O¨S¦³·ÀI¡A¥u¬O¸g¹L¤ÏÂбÀºV¹L«á¡A¦h¼Æ¯E¤Í¬Ý¨ì¤F¬O1,000¤¸¥H¤W(¬Æ¦Ü10,000)ªº»ùÈ¡A Ä@·N·í§ë¸ê®a¡A¦Ó¤£¬O¥u¬°¤FÁÈ100¤¸»ù®t´N¿³°ªªö¯Pªº§ë¾÷¥÷¤l¡C §ë¸ê¯E¹©¤£¦ý¥i¥H°Ñ»P¥xÆW¥Í§Þ²£·~ªº±U°_¡A§ó«nªº¬OY¦³´Â¤@¤é¦¨¬°¥xÆW¤§¥ú®É¡A¤£¦ý¥i¥H³yºÖÀù¥½±wªÌµL¼Æ ¦U¦ì©Ò¾Ö¦³ªº§ë¸ê¦^³øÂ׺Өì´X¥GµLªk·Q¹³ªº¦a¨B¡C±i¸³«e¤TÁûÃij£¦¨¥\¡A¾Ö¦³¦Ê»õ¨»ùªº¤H¤£»Ýn¬°¤F¥u¬°¼´¿ú¦Ó¦A ¨¯W³Ð¥ß¯E¹©¨Ã§ëª`¤ß¤O¸gÀç¯E¹©¤½¥q¤Q´X¦~¡A±q¥L¨¤W§Ú¬Ý¨ì¯E¹©ªº§Æ±æ¡C ¯Î°|ªø¤]¬O¡A±q¨Ó¤£¬O¬°¤F¿ú¦b°µ¨Æ¡A´Nºâ¦³¿ú¤]¬O¦]¬°°µ¨Æ«á¤~¦³ªº¦^³ø¡C ¤¨¦ÑÁó®ö¤l¦^ÀY¡A¦h¤Ö«Ø¿v±M§QµL¨pµLÀv¨Ñ¤H¨Ï¥Î³yºÖ¥þ²y¡A®Äªk¤Úµá¯S¿n·¥¦æµ½¡C ³o¼Ëªº¶Àª÷¤T¤H²Õ¡A¤~¯à³y´N¯E¹©822/833...³o¼Ë¦nªº²£«~³v¨BÁÚ¦V¦¨¥\ªº¾÷½t¡C ºÞ¥L®ü¤j¤á¨C¤Ñ¶R½æ¡A¤j¤á¤S¤£¬OÃĹ¡A´Nºâ¥~¸ê¤]¬O·|¦³»~§P³Q¬½¬½×²zªº®ÉÔ µ¥¨ì¸Ñª¼®É¡A¸Ó¬O¦h¤Ö»ùÈ¡A¥«³õ¤W¦Û·|§PÂ_¡A¤£¬O¥L»¡¤Fºâ »¡¤£©wÁÙ·|¬°300~400¤jÁ|½æ¥X¦Ó«á®¬¤£¤w...¥ý«e¯Î¤j¦W¡A¹pªyÀs¡A´åÃh»È¡Aºa¦w¬î... ¥D¤O¤j¤á¤]¤£¬O³£¯à"³Û¤ôµ²á"ªº¡C¯E¹©·|¤£·|¦¨¬°Ã±¤ý¡A¸Ñª¼¨£¯u³¹§a~~ ÅÒ¤ý ¨D±oÅÒ¤ý¦Ê¨Æ¨} ¸U¨Æ¦p·N¤j¦N©÷ ©y¥[¤O§@¦æ¤è«K ¥i«OºÖ¹Ø¥Ã¦w±d |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2015/4/22 ¤U¤È 09:48:59²Ä 220 ½g¦^À³
|
¹Ç§AÅó±ø±ø¤j ¨º¨Ç¦~«C¤H¥i¯à¬O¨S¦³¦U¦ì¤j¤j¯ë²`¤JÁA¸Ñ822¤Î¥¼°µ¦n§ë¸ê·ÀIºÞ²z,¥[¤W¯Ê¥F°ê»Úµø³¥,¥Í¤â©È¶^,ȱo¦P±¡ ,¦ý¤]¥i¯à¬O¨Ó¾xªº,¦pªG¬O¨Ó¾xªº¨º¬O¯Ê¼w,¥H«á§ë¸ê¤]·|ÁȤ£¨ì¿ú(ºÖ³ø¨Ó¦Û¼w) ©P©ö¤ê¡G¤Ñ¦æ°·¡A§g¤l¥H¦Û±j¤£®§¡F¦a¶Õ©[¡A§g¤l¥H«p¼w¸üª«¡C§g¤l³B¥@¡AÀ³¹³¤Ñ¤@¼Ë¡A¦Û§Ú¤O¨D¶i¨B¡Aè¼Ý°í¨ô¡Aµo¼«¹Ï±j¡A¥Ã¤£°±®§¡F¤j¦aªº®ð¶Õ«p¹ê©M¶¶¡A§g¤lÀ³¼W«p¬ü¼w¡A®e¸ü¸Uª«¡C²MµØ¤j¾Ç®Õ°V§Y¬°¡G¡§¦Û±j¤£®§¡A«p¼w¸üª« AbbVie to Buy Pharmacyclics in $21 Billion Deal http://www.wsj.com/articles/abbvie-to-buy-pharmacyclics-in-21-billion-deal-1425528086 1 Abbvie ¥H210»õ¬ü¤¸¤Ñ»ù¶R¤U Pharmacyclics ( ¦]¬°2Ó¥Õ¦å¯f»P1Ó²O¤ÚÀùÃĪ« Imbruvica ®³¨ì¬ü°êFDA 3 ¶µ¬ð¯}©ÊªvÀø®ÖãBTD ( Breakthrough Therapy Designation) 2 Obi822¨t¦C¥i¬ãµoªºÃĪ«¾AÀ³¯g»·»·¶W¶VImbruvica ,¨Ì¾ÚYK©Ò¨¥¨ÅÀù822Á{§É¸ÕÅ禳¥|Ó¥i¯àªºµ²ªG¤¤Ó¤Hµû¦ô¦³95%¾÷·|¸¨¤Jª½±µ¥Ó½ÐÃÄÃҩάð¯}©ÊªvÀø®ÖãBTD,³o¨âºØ³£ºâ¬O¤j¤j¦¨¥\,¸¨¤Jª½±µ¥Ó½ÐÃÄÃÒ¹w¦ô2016¦~²Ä¥|©uÀò±o¬ü°êFDAÃÄÃÒ,(2016¦~²Ä¤G©u´£¥XNDA) 3¸¨¤J¬ð¯}©ÊªvÀø®ÖãBTD¹w¦ô2017¦~²Ä¥|©uÀò±o¬ü°êFDAÃÄÃÒ( 2016¦~²Ä¥|©u®³¨ìBreakthrough Therapy Designation, ¨Ì¾ÚFDA²Îp®³¨ìBTD«á¥§¡10Ó¤ë·|®³¨ìÃÄÃÒ),¦pªGFDA¤¹¿Õ822´£¦¶i¤J¤T´Á,Àò±o¬ü°êFDAÃÄÃÒ ®É¶¡·|´£¦ 4¨ÅÀù822Á{§É¸ÕÅç¥|Ó¥i¯àªºµ²ªG¤¤²Ä¤T»P²Ä¥|ºØµ²ªG¨Ì¾Ú¤é²±§ëÅU³X½Í³ø§i¤w³Q±Æ°£ ¥H¤W¸ê°T¬°Ó¤H²L¨£´£¨Ñ¤À¨É»P°Ñ¦Ò,½Ð¸Ô¥[¤ÀªR¬ã§P¨Ã¹LÂo¸ê°T,§ë¸êª`·N·ÀIºÞ²z |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2015/4/22 ¤U¤È 06:34:24²Ä 219 ½g¦^À³
|
¹Ç§AÅó±ø±ø¤j 1§Ú̧ë¸ê³o®a¤½¥q±i¸³·í¦~¤j¾ÇÁp¦Ò^¤å¦Ò13¤À,¦A«¦Ò^¤å¥u¶i¨B¨ì26¤À(¼Æ¾Ç¦Ò115¤À ,º¡¤À120¤À,·í¦~¼Æ¾Ç¦³¥[«p¤À,Ãø«×¶W¯ÅÃø)·í¦~»²¤¯¤j¾ÇŪ^¤å·®ð«Ü¦n,¦Ñ¥~ ¯«¤÷ פh«Ü¦h ±i¸³^¤å¹ê¤OÀ³¬O¦b¤j¾Ç¥|¦~¤¤¤k¤Í¹ªÀy¤U§V¤O°ö¾i¥X¨Óªº,¼Ý¤O»P§V¤O¥[¤W¤Ñ®É(Áp¦Ò¥¢§Q¨â¦¸) ¦a§Q(»²¤¯¤j¾Ç) ¤H¦X(¹w¨ì¨}®v¯q¤Í)¬Û°t¦X¤U²¦·~«á®³¨ì³Â¦{ Brandeis University¼ú¾Çª÷¤Î§¹¦¨¤Æ¾Ç³Õ¤h¾Ç¦ì¤Î«á¨Ó¶i¤J³Â¬Ù²z¤u¾Ç°|³Õ¤h«á¬ã¨s Â×´I§¹¾ãªº¸ê¾ú¦¨´N¤@¥Í§Ó·~,¦h¤¸¥¿¦V¤H®æ¯S½è¨ÏµM 2¯Î°|ªø¨ì¥H¦â¦C®³Wolf Prize ,µoªí^¤åºtÁ¿¬O±i¸³ 3§ë¸ê¤@¦ì¸ê¾úÂ×´I§¹¾ã¤Î¦h¤¸¥¿¦V¤H®æ¯S½èªº»â¯èªÌ¬O°§C§ë¸ê·ÀI³Ì«nªº¿ï¶µ,ÆF¬¡ ¾÷´¼ ð· ÅÞ¿è²M´· ¸Û«H Ä@´º ³¥¤ß ²´¥ú ¦æ°Ê¤O¬O¥Lªº¯SÂI ³o¤]¬O§Ú¦b¬ã§P822®É·|±`§i¶D¤j®a¦u®è«Ý¨ßªºì¦] |
|
|
·|û¡G¹Ç§AÅó±ø±ø10135894 µoªí®É¶¡:2015/4/22 ¤U¤È 06:02:50²Ä 218 ½g¦^À³
|
¬Ý¨ì³\¦h¤£¦P·N¨£ªºª©¤Í®Bºj¦Þ¾Ô¡A¹ê¦b¬OY¤£»{¦P¹ï¤è·N¨£¦h»¡µL¯q ¦³·P©ó"¥H¬ì¾Ç¼Æ¾ÚÄYÂÔ¤ÀªR¨Ó¬Ý§ë¸ê»ùÈ"¡A¤@¤Á»Ýn¥Ñ¼Æ¾Ú¨Ó»¡¸Ü¡A¾ã²z¤@¤U¸ê°T ¦pªGÁ٤Ϲ諸¤H¤£¬Û«H±i¸³»¡ªº¡A¨º¤£¥Î¶i¨Ó"¥²´I"ºô°Q½×°Ï¡A¦]¬°±z«Ü¥i¯à»P"¥²´I"µL½t ¦]¬°¸Ñª¼µ²ªG¥i¯à·|: 1. ¹êÅç²ÕPFS»P¹ï·Ó²ÕPFS®t²§¤£¤j --> ¾÷²v=0¡A¦]¬°65%(228/349)ªº¤H¨ì2014/12®É¤w¸g¶W¹L15Ӥ몺Á{§É¸ÕÅç 2. ¦]¦¹100%¥i¥HªÖ©w822¤@©w"¦³®Ä"¡A¥BPFS>15(¹ï·Ó²ÕPFS¤@©w¤p©ó15,¦Ó¹êÅç²ÕPFS¤j©ó15¤~·|¦³³oÓµ²ªG) ±µ¤U¨Ó¬ÝPÈ 2.1 P<0.001 -->ª½±µ¦VFDA¥Ó½ÐÃÄÃÒ --> ¤j¦¨¥\¡Aª½±µ1000¤¸°_¸õ¡AÁöµM¦³10%º¦¶^´T¡A«Ü©êºp,¨C¤Ñº¦°±¶R¤£¨ì 2.2 P<0.05 -->¸ÉFDA¤T´Á --> ¤¤¦¨¥\¡AÀH«K¤]·|500¤¸~800¤¸¡A¦ýn¦A©ì2~3¦~ 2.3 P>0.05 -->קï»P³]p¤T´Á --> ¤p¦¨¥\¡AÁÙ¬O·|¦¨¥\¡A«C«Cµæµæ¤]È320°Õ 2.4 ¤£¥i¯à XXOO ½Ð°Ñ¦Ò2015/3/3ªk»¡·|¡A±i¸³Q&A http://obipharma.blogspot.tw/2015/03/2015333q.html Q1. 822¤T´ÁÁ{§É´_µo©|¥¼±Ò°Ê´Á¤¤¤ÀªR¡A¥i¨£´_µo¤H¼Æ¥¼¹F´Á¤¤¤ÀªR¤§142¤H¡A½Ð°ÝPFS¬O§_¹F20Ó¤ë¡H®t¶Z¦³¦h¤j¡H Michael¡Gµª®×¨ä¹ê¥u¦³¤@Ó¦r¡A¦ý§Ún¥Î¤@¤j¬q¸Ü¨Ó»¡©ú¡C·íªì¹w©w´Á¤¤¤ÀªR¬O¥H´_µo¤H¼Æªº¤@¥b142¤H¬°¤ÀªR¼Ð·Ç¡A«e¨âÓ¤ë´_µo¤H¼Æ¤´¥¼¹F´Á¤¤¤ÀªR¼Ð·Ç¡A¦Ó¥B¤w¸g¦¬§¹©Ò¦³ªº¯f¤H¡A¦]¦¹´Á¤¤¤ÀªR¤w¸g¨S¦³·N¸q¡A¨ú®ø¤F¡C .......«á¨Ó¦bÁ{§É¹êÅ礦~«áµo²{¡A´_µo¤H¼Æ¸û·íªì¹wpªºn¤Ö«Ü¦h¡C........ Q2.822¥Ó½Ð¸Ñª¼®É¶¡ÂI»P¸Ñª¼±ø¥ó¡H Michael¡G³Ì«á¤@Ó¯f¤H¥h¦~8¤ë¦¬¡A9Ó¤ëÀøµ{¥i¥H¥´§¹9°w¡A¹wp¤µ¦~5¤ëÀ³¸Ó©Ò¦³¯f¤H³£À³¸Ó¥´§¹¡A¤µ¦~8¤ë³Ì«á¤@Ó¯f¤H¦³12Ӥ몺Àøµ{¡C§Ú̪ºCT(Á{§É¸ÕÅç)¦³§ï¨}¦¡ªº³]p¡A«ùÄò¦b¶i¦æ¡A¼Æ¾Ú¤£Â_¦b¦¬¶°¡C¦pªGÃĮīܦn¡A´_µo¤H¼Æ¤£¦h´N¥i¥H¸Ñª¼¡A¦ý¬O¤]¦s¦bµÛ·ÀI¡A¸U¤@²Îp¼Æ¾Ú¤£¨ì¹F¦³·N¸qªº¼Æ¦r¡A´N·|¦³«á¿ò¯g¡C§Æ±æ§ë¸ê¤H¬Û«H§Ú̹ζ¤¡A§Ú̬O«D±`¦³¸gÅ窺¡A·|°µ¥¿½Tªº§PÂ_¡C Q5.¤½¥q´¿«Å¥¬2015¦~·|®i¶}¬ü°ê¤T´Á¡A¦ó¬G¶i«×©µ«á¡H²Ä¤T´Áªº¥þ²yÁ{§É¸ÕÅç³W¼Ò¹wp¦¬®×¦h¤Ö¤H¡H¦bþ´XÓ°ê®a®i¶}¡H Michael¡G©µ«áì¦]«Ü²³æ¡A·íªì¦b³]p¬OPFS¦b6~9Ӥ몺§ï¶i¡A¨S·Q¨ì´_µo¤H¼Æ¤ñ¹w´Á¦n¡A¦b¥¼¹F´_µo¤H¼Æ±¡§Î¤U¡AµLªk§Ö³t¸Ñª¼¡A¦Ó¬ü°ên¶}©l¤T´Á»Ýn¨Ì¾Ú¥xÆW¤T´Áªºµ²ªG×¥¿Á{§É³]p¡A©Ò¥H¦³¨Ç©µ»~(¤]´N¬O»¡©µ«áì¦]¬O¦]¬°ÃĮĤӦn)¡C ³o¬OÂù±¤b¡AÃa®ø®§¬O·|©µ«á¡A¦n®ø®§¬O§ÚÌì¥ý§Æ±æ¥unPFS 6~9Ó¤ë§ï¶i50%¡A»Ýnªº¤H¼Æ«D±`¤Ö¡Aì¨Ó¹wp¤T´ÁÁ{§É500~800¤H¡A¥i¯à´î¤Ö¦¨¬°1~200¤H¡A·|´î±o«D±`¤Ö¡C Q7.¬°¦ó822·í®É¿ï¾Ü¨ÅÀù¡H°£¤F¨ÅÀù»P§Z±_Àù¡A¤U¤@Óµo®iªº¾AÀ³¯g¡H Amy¡G¥þ²y¦³¤TÓGroupªºÂå¥Í¦bÀ°¦£¯E¹©¡A²Ä¤@Ó¬ODSMB¡A¥DnµÛ«¦bSafety¡A¥t¥~¤@Ó±Mª`©ó¥þ²y¤Æªºµo®i¡A²Ä¤TÓ¬OÆ[¹î¦UºØÀù¯gªº¾A¥Î©Ê¡A²{¦b¤w¸g¦b³]pProtocol¡C¥t¥~Lung Cancer ¥¿¦b»P¥x¤jÂå°|¦X§@¡Cì«h¤W¥«³õ¤j¡AÂåÀø¤W¨S¦³ÃĪº¡A·|Àu¥ý°µ¡C C34(¦õ¾¯)¬O¸ò¤¤¬ã°|License¡Aì¥ý³]p¬O¨Ï¥ÎC34§@¬°833ªº¦õ¾¯¡A¬O¤@Ó·sªº²£«~¡A¬ãµoªø«Øij¤£n¤@¦¸§ï¨âÓ(¸üÅé¡A¦õ¾¯)¡A«á¨Ó²Ä¤G¥N833¨M©w¥u§ï¤@Ó(¸üÅé)¡A¤£§ï¦õ¾¯(¨Ï¥Îì¨Óªº821¨Ï¥ÎQS21)¡CC34¤w¸gFormulation°µ¦n¡A±N¨Ó·|¨Ï¥Î¡C Q10.¦pªGÁ{§É¼f®Ö¤£¦p¹w´Á¡A¦³¦ó³Æ®×¡H Michael¡G¦pªG²£«~¨S¦³Àø®Ä¡A§Ú̦³«Ü¦hӳƮסA¦ý¬O¥Ø«e¨Ó¬Ý¡A¨S¦³¥²n¡C ¸U¤@¸Ñª¼®É¨S¦³²Îp¤Wªº·N¸q¡APȨS¦³¹F¨ì¹w´Á¼Ð·Ç0.05¡A«ç»ò¿ì¡H¤@¯ëFirst In Class Breakthrough Therapy´Nºâ¨S¦³¹F¨ì0.05¡A¦pªG¯f¤H¨S¦³¦w¥þÅU¼{¡A¦Ó¥BÀø®Ä¨ãSignificant¡AÁÙ¬O·|㤩Conditional Approval¡C³oÀ³¸Ó¬O³ÌÃaªºª¬ªp¡A¤]´N¬O»¡¸Ñª¼ªº®ÉÔPȤ£¨ì0.05¡A³o´N¬O³Æ®×¡C§Ú̧Ʊæ¦b°µ¨Æ«e«ä¦Ò¤ÀªRªº®ÉÔ¡A«D±`ºë·Ç¡C Q13.822¦b¥xÆW¤T´Á¸Ñª¼«á¡A¦pªGµ²ªG¥¿±¡A¬ü°ê¥i§_ª½±µ¥Ó½ÐÃÄÃÒ¡H©Î¬On°µPhase III¤§«á¤~¥i¥Ó½ÐÃÄÃÒ¡H YK¡G²{¦b¦bÁ{§É¤W¦³349Ó¯f¤H¡A¦b¥xÆW¬O²Ä¤T´Á¡A¬ü°ê¬OPhase IIb(Proof of Concept Trail¡A¤SºÙ¬°PoC trial¡A·§©ÀÅçÃÒÁ{§É)¡A¦ý¬O©Ò¦³¹B§@ªº³W®æ¬O®Ú¾ÚGlobal Phase III³W®æ¦b°µ¡C³oÓÃÄ«D±`¦w¥þªº«e´£¤U¡A¤µ¦~©Î©ú¦~¬YӮɶ¡¨M©w½µP¡AÁ{§É¸ÕÅ禳¥|Ó¥i¯àªºµ²ªG¡C (1)¤@±ì¶i¬}¡A¤]´N¬O»¡®ÄªG«D±`¦n¡APȫܤp¡A¤p©ó0.001¡A§ÚÌ·|§V¤O¸òFDA¡A¸ò¥L̽ͧPª½±µ¥Ó½ÐProvisional Approval(¼È®É®Öã)¡C¥i¯à©Ê©O¡H³o¬O²Ä¤@Ó¥D°Ê§K¬ÌÀøªk·sÃÄ¡A¥i¯à©Ê¬O¦³¡A¦ý¬O«e´£¬O³oÓÃÄn«D±`Robust(¦³¤O¶qªº)¡C (2)·Ó§ÚÌÁ{§É³]p¡AÃĮĤ£¿ù¡A¤]ºâ¦¨¥\¡A³o®ÉÔ·|ª½±µ¸òFDA¥Ó½ÐBreakthrough Therapy¡A¦P®É·¾³q¦A¸É²Ä¤T´Á¼Æ¾Ú¡A¼Ú¬w¤]¬O¤@¼Ë¡A¦]¬°²{¦bªºPhase II¥i¥H§@¬°Supporting Phase III¡C (3)½µP¤§«á¡Aµ²ªG¦³®Ä¡A¦ý¬O¤£²Å¹w´Á¡A´N¥Î¦³µ²ªG¡A¥h¾Þ§@³]p¤U¤@ÓÁ{§É¹êÅç¡A«ü¥X¤@±ø©ú½Tªº¸ô®|¡C (4)§¹¥þ¥¢±Ñ¡A¥i¯à©Ê¤£¤j(¦ý¬O¨S½µP¤§«e¥i¯à©Ê³£¦³)¡C |
|
|
·|û¡G¹Ç§AÅó±ø±ø10135894 µoªí®É¶¡:2015/4/22 ¤U¤È 12:56:39²Ä 217 ½g¦^À³
|
¥xÁÞ¤j¡A±z¼gªº¯u¦n¡A¤p§Ì^¤å³y¸Ú»·¤£¤Î§A¡A±zªº¦r¦r²¼ä«o¹D¥XÀ³¹D²z ¥ð®§¬O¬°¤F¨«§ó»·ªº¸ô¡A³Ìªñ¤j®a³£¦bºÆ¤ôªG"²~»\ªÑ"¹³¤j²É¥ú°Õ¡A¥i¼°Õ...¥Í§ÞªÑ¥u¦n¼È°±µo¥\ ¥HÄw½X±¦Ó¨¥½T¹ê¯E¹©¤WÂd«e«á§l¤Þ¤Ó¦h´²¤á¶i³õ¡A§j½K¤@¦À¬K¤ô¡A³o¨ÇÄw½X¨S¦³¨I¾ý(³Q¬~¥X¨Ó)®É¬OÃø¦³ªí²{ ¨ØªA¥[¤jªº¿ïªÑ«ùªÑ¯à¤O¡A¯à°÷±q1700~2955µ¹¤j²É¥úÅó±ø±ø¡AÁa¨Ï3000¥H¤W¤S¦p¦ó¡A³ÌÂ׺Ӳ¢¬üªG¹ê±z¤w¨É¥Î ¯d¨Çµ¹¥½¯Z¨®ªº¦P¦n¤]¤£¿ù ¤£ºÞ¤j¤á¤H®a·Qn¦h¤Ö¿ú¶R¡A¥un¥¼¨ÓªÑ»ù¯à°÷¨ì1000¥H¤W®É¡A400/320/250/120...³£Áȫܦh¡A¨C±iÁȪºª÷ÃB¨ä¹ê®t¤£¤F¤Ó¦h¡A¦Ó³Ì¤j®t§O¨ä¹ê¬O¾Ö¦³ªº±i¼Æ¡A¥[¤jY½æ±¼¤j²É¥ú5±i¦³1500¸U¥i¥H¶R¯Eô§Ö50±i ¨ì®ÉÔ¤ñ°_¥u¶R5±iªº¤HÀò§Q·|¬O10¿¡A·íµM¶^®É¤]·|®t10¿¡A¦ý¬O¥¼¨Ó¥i¯àÀò§QµLªº¥i¯à©Ê·|¹ê²{§r Just do it, You can make it. |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2015/4/21 ¤U¤È 01:44:37²Ä 216 ½g¦^À³
|
«¶Kª©: ¤H®æ¯S½è§ï¥Î¦æ®eµü¸û¾A·í ·QÁA¸Ñ±i¸³½Ð·j´M:±i©À·O ¨D·s¡B¨DÅÜ¡B¨D¦nª± ±i¸³¯à¦b¥Í§Þ¬ÉÂô¤U¤@¤ù¤Ñ¦Û¦³¨ä»P¤H¤£¦Pªº¤H®æ¯S½è,³o¨Ç¯S½è¤£¬Oª÷¿ú¯à¶R¨ìªº 1Åé¾z±j°·¡A³ßÅw·¥¹B°Ê¡AÃM°¨¡BÃk©¥ ¶}¹C¸¥¡B¹C¼Ú¬ü¡A²î®é¹M¾ú¦U¤j¬v( «_ÀI ®öº© ¼ÖÆ[ ¼ö±¡....) 2¯d©f´Á¶¡¦b¤¤¦¡À\ÆU¥´¤u·í¤G¼p¡A½m´N¤F¤@¨¼pÃÀ¡A¤]Äw³]¨âÓÀ\ÆU·í¦ÑªO (¦h¤~¦hÃÀ ... 3¦b¬ü°êªA°È¥Í§Þ¤½¥q´Á¶¡¦³¤TÁûÃÄÀò±oFDA®Öã¤W¥« ¨CÁûÃĦ~¾P°â³£¹F10»õ¬ü¤¸ (¸gÅç ²´¥ú ȱo«H»{ ±Mª`ªº.. ) 4^¤å¦Ò¤£¦n«á¨Ó³ºµM¯à¶i³Â¬Ù²z¤u¾Ç°| Ū®v¤jªþ¤¤®É¼Æ¾Ç³»¦y (¼Ý¤O»P°í«ù ÅÞ¿è«äºû¯à¤O·¥¨Î ) 5³Ð¥ß¯E¹©¥Í§Þ¤½¥q(¦³³¥¤ß ³Ð·s ¦³¸gÅç «©Ó¿Õȱo«H¥ô) §ë¸ê¥Í§Þ¤½¥qn§ë¸ê¤H ´x²ëªº¦ÑªO¯S½è¨M©w¬O§_822·|³Q FDA®Öã(approval) »P ±µ¨ü( Accept ) Farsighted ¦³²´¨£ªº Dramatic ¤Þ¤Hª`¥Øªº Adventurous«_ÀIªº Ambitious ¦³³¥¤ßªº Passionate ¼ö±¡ªº persistent °í«ùªº Romantic ®öº©ªº Optimistic ¼ÖÆ[ªº Versatile ¦h¤~¦hÃÀ Attentive ±Mª`ªº logic ¦XÅ޿誺 Amiable ©Mħ¥i¿Ëªº «p¹Dªº Confident ¦³«H¤ßªº Creative ³Ð·sªº Experienced ¦³¸gÅ窺 Patient ¦³@¤ßªº Trustworthy ȱo«H¥ôªº |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2015/4/21 ¤U¤È 12:11:02²Ä 215 ½g¦^À³
|
·QÁA¸Ñ±i¸³½Ð·j´M:±i©À·O ¨D·s¡B¨DÅÜ¡B¨D¦nª± ±i¸³¯à¦b¥Í§Þ¬ÉÂô¤U¤@¤ù¤Ñ¦Û¦³¨ä»P¤H¤£¦Pªº¤H®æ¯S½è,³o¨Ç¯S½è¤£¬Oª÷¿ú¯à¶R¨ìªº ¤]¨M©w¬O§_822·|³Q FDA®Öã(approval) »P ±µ¨ü( Accept ) Fearlessness «i´± Dependence ¿W¥ß Adventure «_ÀI Ambition ³¥¤ß persistness°í§Ô passion ¼ö±¡ Romantic ®öº©ªº¤H Optimistic ¼ÖÆ[ Value »ùÈ Attentiveness ±Mª` logic ÅÞ¿è©Ê Amiable «p¹D Confidence «H¤ß Creation ³Ð·s Experience ¸gÅç Patience @¤ß Trustworthiness ȱo«H¥ô |
|
|
·|û¡G¥[®³±j10140200 µoªí®É¶¡:2015/4/20 ¤U¤È 08:32:13²Ä 214 ½g¦^À³
|
¤µ¤Ñ§Ú¤S¶R¶i5±i320¨ì322 |
|
|
·|û¡G¹Ç§AÅó±ø±ø10135894 µoªí®É¶¡:2015/4/20 ¤U¤È 04:10:11²Ä 213 ½g¦^À³
|
·sÃĪº»ùÈ: http://aspe.hhs.gov/sp/reports/2014/antibacterials/rpt_antibacterials.cfm «e±¥|¤À¤§¤@³B¦³±i¹ÏFigure 2: Drug Development Decision Tree Depicting Expected Net Present Value (ENPV) of Private Returns (Values in $ Million) for a Hypothetical New Molecule X ¥u¬O¤@Ó°²³]ªº®×¨Ò¡A³oӮרÒENPVÁ{§É«e62M¡A1´Á230M,2´Á£¿465M,3´Á809M,·sÃļf®Ö1265M,¦¨¥\¤W¥«1509M(³æ¦ìMªí¥Ü¦Ê¸U¬ü¤¸) 822¦pªGµe³oÓ¨Mµ¦¾ðENPV·|¬O¦h¤Ö? ÀH«Kºâ50»õ¬üª÷³£¦³1000¤¸¥H¤W¡A§ó¦óªp³oÓ¥u¬O822¥DµæÁÙ¥¼ºÝ¥Xªº¤pµæ»ùÈ ¥Dµæ¥X¨Ó·í5¿¡A10¿©ó¦¹¡C ¤j¤á¤H®a»¡ªº¤£ª¾¹D³Ìªñ¦b¶^¤°»ò¡A«Ü²³æ¡A¦]¬°¥Í§ÞªÑ¨S¦³¤@ÀÉ¥i¥Hªñ´Á¦³«¤j§Q¦h¡A¦Ó³°ªÑ´äªÑ¬Æ¦Ü¥xªÑÁZÀu¹q¤lªÑ³£±j¤O§lª÷¥h¡A¯R(¥D¤O)¤£¯k®Q(´²¤á)¤£·Rªº¥Í§ÞªÑ¦¨¤F´Î¥´¸¨¤ôª¯¡CºÞ¥L¬O°¨º¸ÀÙ´µ¡B¶Q»«¡B¦N«½«½ÁÙ¬O³Õ¬ü¡A¥þ³¡·í¦¨Äîµgª¯¥´¡C ¥unª¯¨S³Q¥´¦º¡A¹L¬q®É¶¡«ì´_¤¸®ð¡A´«Ó¦³·R¤ßªº¥D¤H¬~¾þ¬ü®eSPA¤@¤U¡A°Ñ¥[°ê»Ú¿ï¬üÁɱo¼ú«á°¨¤W¦³¤H°ª»ù·mÁÊ¡C ²{¦b³o±ø¸¨Ãøªºª¯¦³¾÷·|Åý§Ú̦¬¾i¡A¬OÀ³¸Ó¦n¦n¬Ã±¤©êºòºò¡AÁÙ¬O¬½¬½¬r¥´¤@¤U¦¨¬y®öª¯¡A¥«³õ¤W«Ü¦h¤H³£¦b¹ï°µ¡C |
|
|
·|û¡G¤ý£«¬Â10136621 µoªí®É¶¡:2015/4/20 ¤U¤È 01:13:50²Ä 212 ½g¦^À³
|
¸Ñª¼«e³oªÑ»ù¥u¯àÀH®ø®§±¤W¤UÄÆ,¤@¤Á¦p¦P¾h¤j»¡:µ¥.µ¥.µ¥..... |
|
|
·|û¡G¹Ç§AÅó±ø±ø10135894 µoªí®É¶¡:2015/4/20 ¤W¤È 11:59:36²Ä 211 ½g¦^À³
|
¥xÁÞ¤j¡A °ª¤â¤§»¡·\¤£´±·í¡A§Ú·Q¤j®a³£¬O¼f·V¼ÖÆ[¦b¬Ý822Á{§Éµ²ªG ¤j¥ß¥ú¤µ¤Ñ½L¤¤¤w¸gº¦¤F100¤¸,¬ð¯}2900Ãö¥d¡A¬Ý¨Ó3000¤¸«ü¤é¥i«Ý °O±o2011¦~6,7,8¤TÓ¤ë¡A¤j¥ß¥ú³£¦©Ãö1000¤¸¦¨¥\¤T¦¸¡A¨Ó¨ì¾ú¥v°ªÂI1005¤¸ 9Ó¤ë«áªº2012¦~5¤ë¨Ó¨ì451¤¸¦aÂI¡A¾ã¾ã¤U¶^55%, µM¦Ó2012¦~5¤ë¤§«á¦ñÀHµÛ´X¥G³£¬O¤ë¬õk½uªº±¡§Î¤U¡A1¦~«áªº2013¦~5¤ë¡A¦A«×¨Ó¨ì1005¤¸ ¸ò¥ý«e¤T¦¸¤£¦Pªº¨Æ¡A¦A1¦~«áªº2014¦~5¤ë¥¿¦¡¬ð¯}2000¤¸ ·|¤£·|¦A1¦~«áªº2015¦~5¤ë(ÁÙ¬O4¤ë?)¡A¥¿¦¡¬ð¯}3000¤¸? ¤j®a³£¦b¬Ý ¯E¹©±q450°ªÂI¶^¨ì¥Ø«e320, ±Nªñ30%,¤´¥¼¤Î¤j¥ß¥úªº55%, ¦pªGn¶^¨ì55%, ¥u·|³Ñ¤U200¤¸ ²{¦b320®É¡A¬On¶RÁÙ¬On½æ? ¨CÓ¤H³£¦³½Lºâ ¤j¥ß¥ú4¦~«e1005,3¦~«e451, 2¦~«e1000, 1¦~«e2000,¤µ¦~3000+ ? ¯E¹©¬O¤£¬O¸ò¥L«Ü¹³¡A±q100, 200, 450 --> 320 --> ??? ¤j¥ß¥ú±q§CÂI451¨ì²{¦b2900, º¦¤F6¿¡A§Y«ù¦³ªº¤HÁȤF500% ¬Û«H¯E¹©822¦¨¥\ªº¸Ü, 320 * 6 = 2000¤¸¤]µS¦p±´Ån¨úª« ¥u¬O»Ýn¤@Ó¦r "µ¥", ¤TÓ¦rªº¸Ü¤]¬O "µ¥¡Bµ¥¡Bµ¥" ±z»Pª©¤W½Ñ¦h°ª¤â³£µS¦p¬O§Ú·q«ªº¾É®v¡A±N±a»â¯E¤ÍÌ·f¼"¥xÁÞÄ¥¶¤"¤@¸ô"¼·¯}®ö"¡A¨£ÃÒ¥xÆW·sÃÄ©_ÂÝ |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2015/4/19 ¤U¤È 11:50:18²Ä 210 ½g¦^À³
|
§ó¥¿ ¹Ç§AÅó±ø±ø¤j³o¤@ª©¶K¤å¤£¦h¡A¥L»P°e³ø¤j³£¬O¥»ª©°ª¤â¡A §Æ±æ¦U¦ì¤j¤j¦h¤À¨É¸ê°T¡A¥u³Ñ³Ì«á¤@¯@¸ô¡A¤¨¸³¤wqªº¡A ²î¤C¤ë´Nn¥æ²î¡AÀ³¬On¼y¯¬822ªº¦¨¥\«á¬°Àô¹C¤j®ü©Ò§@ªº·Ç³Æ |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2015/4/19 ¤U¤È 11:29:07²Ä 209 ½g¦^À³
|
°e³ø¤j³o¤@ª©¶Kªº¤H¦n¹³¤£¦h¼Æ¡A¤£n¨ü¤@®ÉªÑ»ùªi°Ê·n·íªì§ë¸êªºªì°J¡A Faith¤j ®Ñ¤¤´£¨ì¦s¬¡²vÀ³pºâ¨ì¥h¦~¤C¤ë¥xÆW¤j¾ÇºtÁ¿¬°¤î¡A¦pªG¦p®Ñ¤¤©Ò¨¥¤j®a§óÀ³°í«H¦Û¤v¥ý«e§PÂ_¡A ¬ü°ê¤G´Á®ÄªG¦³¬Û·í¤ô·Ç¤~´±¦V¬ü°êFDA¥Ó½Ð¤T´Á ¤£½×YK©Ò´£¬O²Ä¤@ºØ©Î²Ä¤GºØ±¡ªp«á±³£»Ý¸É¥æ¤T´ÁÁ{§É¸ê®Æ ´£«e±Ò°Ê¡AÀ³ÄݧQ¦h¡AÓ¤H¬ã§P²Ä¤TºØ±¡ªp¾÷²v¤p©ó5% ²Ä¥|ºØ±¡ªp¾÷²v¬O0 ¥Í§Þ¤½¥q¶¡©¼¦¹Ävª§¤O¡A¦U¦³¦U°Ó³õ¬ãµoµ¦²¤¡Aµêµê¹ê¹ê¡A¥Ã»·nÂ\²æ¥Ø«e»ø¤Æªº»{ª¾»P·Qªk¤~¦³¥i¯à¸õ²æ®Ø¤ºªº«äºû ¦bÅܰʤ¤ºë½T´x´¤¥i¯à¨Æ¥óªº¬ã§P¬Û·í¤£®e©ö¡An±qµïµ·°¨¸ñ¤¤§ä¨ìÄÝ©ó¦Û¤vªºÅå©_ |
|
|
·|û¡G°e³øªº10135990 µoªí®É¶¡:2015/4/12 ¤U¤È 12:52:43²Ä 208 ½g¦^À³
|
§ó¥¿ºô§} http://www.y-lp.com/pages/Article.aspx?id=4731692211151908589 |
|
|
·|û¡G°e³øªº10135990 µoªí®É¶¡:2015/4/12 ¤U¤È 12:49:56²Ä 207 ½g¦^À³
|
±j°êªºÆ[ÂI©M¾ã²z ½LÂI¡G¥v¤W³Ì¸ÔºÉªº¸~½F§K¬ÌÀøªk¥«³õ¤ÀªR http://www.y-lp.com/pages/Search.aspx?keywords=%e5%8f%b2%e4%b8%8a%e6%9c%80%e8%a9%b3%e7%9b%a1%e7%9a%84%e8%85%ab%e7%98%a4%e5%85%8d%e7%96%ab%e7%99%82%e6%b3%95%e5%b8%82%e5%a0%b4%e5%88%86%e6%9e%90 |
|
|
·|û¡G°e³øªº10135990 µoªí®É¶¡:2015/4/12 ¤U¤È 12:16:04²Ä 206 ½g¦^À³
|
±i¸³¦b¥»´Á°Ó·~¶g¥Z¤S¦³·sªº¶}ÄÀ.. ¦ý·N¹Ò¤Ó°ª.¤pªº¸ûÃø¾ã²z..(¶Â´ËªL¤¤ªº¥ú) ¦³½Ð¦U¦ì¤j¦Û¦æ°Ñ¸Ô.. 쥻¥i¥H²³æ¦^µªªº°ÝÃD.²{¦b³£n¥Î¶¤@¤j¬q¨Ó¸ÑÄÀ..µL©`.. |
|
|
·|û¡G¤p©_10138298 µoªí®É¶¡:2015/4/11 ¤W¤È 09:05:36²Ä 205 ½g¦^À³
|
µoªí¤å¦r¡B¬Ýªk »Ýnªº¬O®É¶¡ ¡Bºë¯« ¡B¼ö¤ß¤ÎÁä½L ¤£»Ýn¥Î¨ì«i®ð³á¡I |
|
|
·|û¡G10139510 µoªí®É¶¡:2015/4/10 ¤U¤È 11:26:00²Ä 204 ½g¦^À³
|
°êX ³ø§iªºªí2Åã¥ÜIbrance»PAfinitorªº2018 ¦~¹w¦ô¾P°âÃB¤£¬Û¤W¤U ¡]29.51»õ¤ñ30.81»õ¬ü¤¸¡^¡CÁöµM¨âªÌ¤£¬O¦PÃþÃÄ¡]Afinitor¬OmTOR inhibitor¡AIbrnace¬OCDK-4/6 inhibitor¡^¡A¦ý¦P¼Ë¬O¥Î¨Ó»²§U²üº¸»XªvÀøÃÄLetrozole ©Î Exemestane ¡]³o¨âªÌ¬O¦PÃþAromatase inhibitor¡^¥H©µ½w¨ÅÀù´_µo¡]PFS¦P¼Ë¬O©µªø¨â¿¨ì¤T¿¤§¦h¡AIbrance¥Ñ10Ó¤ë¨ì20Ó¤ë¡AAfinitor¥Ñ4Ó¤ë¨ì11Ó¤ë¡^¡C©Ò¥H°êXªº¹L«×±j½ÕIbrance¦³10Ó¤ëPFSªºÐä±o¬°¨äÃÄ®ÄÀu¶Õ¬O¯¸¤£¦í¸}ªº¡A¦]¬°Afinitor ¥u¦³7Ó¤ëPFSªºÐä±o¨º¤£´N¸Ó»·¿é©óIbrance¤F¹À¡C±M®a̦b·Nªº¬O¤@Ó·sÃĤñ°_¦Û¤vªº¹ï·Ó²Õ¦³´X¿¦n³B¡]Ibrance¡G2¿¡AAfinitor¡G2.75¿¡^¡A©Ò¥HIbrance»PAfinitorªº2018 ¦~¹w¦ô¾P°âÃB¤~·|¤£¬Û¤W¤U¡C822ªºPFSn¤£n¦n¨ì20Ó¤ë¤~¥s®y¡A©Î¬O11Ó¤ë´N°÷¦n¡A¨º´N¥þ¬Ý¨ä¹ï·Ó²ÕªºPFS¬O±µªñ10Ó¤ë©Î4Ó¤ë¡I |
|
|
·|û¡Gjack10139694 µoªí®É¶¡:2015/4/10 ¤U¤È 11:25:15²Ä 203 ½g¦^À³
|
·PÁ³o¦ì¤j¤jÄ@·N¥X¨Ó¾É¥¿¿ù»~ªº½×½Õ ÁÂÁ§Aªº«i®ð |
|
|
·|û¡G10139510 µoªí®É¶¡:2015/4/10 ¤U¤È 11:19:01²Ä 202 ½g¦^À³
|
http://www1.cde.org.tw/ct_taiwan/search_display_list3.php?testphase=Phase%26nbsp%3B%A2%BA%2CPhase%26nbsp%3B%A2%BB&pagenow=3 n¤Ä¿ï ¶Èµo¥Í°©Âಾªº±wªÌ¤£¯à¯Ç¤J¥»¸ÕÅç¡AµM¦Ó¡A ±wªÌ¥Ø«e¶È«]©ó°©Âಾ¡A¦³¨ä¥L»·ºÝÂಾ¯f¥vªÌ¥i¯Ç¤J¥»¸ÕÅç¡C ±wªÌ¥Ø«e¶È«]©ó°©Âಾ¡A¥B¨Å©Ð¦³Àù¯g¯f¨_ªÌ¯Ç¤J¥»¸ÕÅç¡C ¦bÁ{§É¤W¡A¬°¤F¤è«K°_¨£¡A³q±`±N¨ÅÀù¤À¬°¥|´Á¡G ²Ä¤@´Á¢w¢w¨ÅÀù¤ºªºµw¶ôª½®|¤p©ó¢±¤½¤À¡AµLµh©Ê¡C¨ÅÀù§½¦b¨Å ©Ð²Õ´¤º¡AÁÙ¨S¦³²O¤Ú¸¢Âಾ¡C ²Ä¤G´Á¢w¢w¨Å©Ð¤ºµw¶ôªºª½®|¦b¢±¡ã¢´¤½¤À¤§¶¡¡A¨Å©Ðªí±ªº¥Ö½§ ¥i¯à¨ü§è²o¦Ó¥W³´¡BµäÁY¡A¨Å©Ð·|»´·L¤£¾A·P¡A¦¹´Á¥i ¯à¦³©ÎªÌ¨S¦³²O¤Ú¸¢Âಾ¡C ²Ä¤T´Á¢w¢w¨Å©Ð¤ºµw¶ôªºª½®|¤j©ó¢´¤½¤À¡A¨Å©Ðªí±¥i¯à¥X²{¼ìºÅ ©Î§e¾ï¥Ö¼ËÅܤơA¨ÅÀY¥i¯à¦³²§¼Ëªº¤Àªcª«¡C²O¤Ú¸¢¤w ¦³Âಾ¡C ²Ä¥|´Á¢w¢w¨ÅÀù¤w¸gÂX´²©M½¯©µ¡A¨Ã²£¥Í»·³BÂಾ¡A³Ì±`¨£ªº¬OÂà ²¾¨ì°©ÀY¡BªÍ¡B¨x¡B¸£µ¥¾¹©x¡C ©Ò¥H¬O¥u¦¬²Ä¥|´Á¯f±w¡C |
|
|
·|û¡G¯ä¦Ñ¹«10139175 µoªí®É¶¡:2015/4/2 ¤U¤È 12:16:08²Ä 201 ½g¦^À³
|
¹Ç¤j ¤p§Ìè²³æ¬Ý¤F¤@¤Uªk°ê¨º½g¸ê®Æ ¨ä¤¤´£¨ì¤ÀªRªº560ӮרҤ¤ ³æÂIÂಾªº¬O311¤H ¦hÂIÂಾªº¬O249¤H «ö·Ó¨ÅÀù¤À´Á©w¸q³æÂIÂಾªº¬O2´Á»P3´Á¡A¦hÂI(»·ºÝ)ÂಾªºÄÝ©ó4´Á ¥Ñ¦¹¥i¨£¸Ó¸ê®Æªº16.3Ó¤ë¬O2´Á3´Á±wªÌ©Ô°ª ³æ³æ¥|´Á¤£¥i¯à¹F¨ì16.3Ó¤ë ¦Ó¯E¹©¦¬®×²zÀ³"³£¬O4´Á"~~~~~~~¡A©Ò¥H¹ï·Ó²ÕPFS¤£¥Î¦ô¨ì10Ó¤ë ANYWAY¡A§Ú̶V«O¦u¶V¯à°§CÂÕ»~ªº¾÷²v «D±`ÁÂÁ±zªº±Àºâ |
|
|
·|û¡G¦aºG¤j¦ë10138763 µoªí®É¶¡:2015/4/2 ¤U¤È 12:06:23²Ä 200 ½g¦^À³
|
½Ð°Ý ¦pn¸Ñª¼¬O§_·|¥ý¤½§i?? |
|
|
·|û¡G¹Ç§AÅó±ø±ø10135894 µoªí®É¶¡:2015/4/2 ¤W¤È 11:18:27²Ä 199 ½g¦^À³
|
¥Ø«e¯E¹©³Ì¤j¹ï¤â¬O½÷·çlbrance¡APFS=20.2, ¹ï·Ó²Õ10.2 ©Î¬Où¤óªºCombining PERJETA with Herceptin + docetaxel PFS=18.5 ¥H2014/12/31¥¼¹F´Á¤¤¸Ñª¼±ø¥ó,´_µo¤H¼Æ¤£¶W¹L130¤H¨Ó¤ÀªR¡A³]p2Ó¼Ò«¬¡A 1.¹ï·Ó²ÕPFS=10(¥[p¶Pº¸»XÀøªk¥i¯àªº®ÄªG),¹ï·Ó²Õ´_µo70¤H¡A¹êÅç²Õ´_µo¤£¶W¹L60¤H 822 PFS>24 2.¹ï·Ó²ÕPFS=6 (¦p¤½¥q³Ìªì³]p)¹ï·Ó²Õ´_µo90¤H¡A¹êÅç²Õ´_µo¤£¶W¹L40¤H 822 PFS>36 ¦p¦P¤½¥qªk»¡·|©Ò»¡ªº"822ÃĮĤñ¹w´Á¦n¡A¦]¦¹¤£¶i¦æ´Á¤¤¤ÀªR¡A¥¼¨Óª½±µ¶i¦æ¸Ñª¼" ±À¦ô¤½¥q¬O¦b§ä³Ì¨Î¸Ñª¼®É¶¡¨ä¹ê¤£¬O¬°¤FP Value<0.001, ¦Ó¬O¦]¬°822¹êÅç²Õ´_µo¤@ª½¥¼¹F1/2¤H¼Æ ¦pªG822¹êÅç²Õ´_µo¤@ª½¥¼¹F1/2¤H¼Æ¡A·íµMµLªk±oª¾822 PFS ¥²¶·¥ý¨ú±o822¹êÅç²Õ¤@¥b¥H¤Wªº´_µo¤H¼Æ«á¡A¶i¦æ¸Ñª¼¤~¦³·N¸q ±µ¤U¨Ó¹w¦ô¸Ñª¼®É¶¡¡A 1.Y822 PFS=24,¸Ñª¼®É¶¡·|¦b2015¦~10~12¤ë 2.Y822 PFS=36,¸Ñª¼®É¶¡·|¦b2016¦~6~9¤ë 3.Y822 PFS>36,¸Ñª¼®É¶¡·|¦b2016¦~9¤ë¥H«á ¯uªº¬O"ÃĮĶV¦n¡A¶V±ß¸Ñª¼"¡A¦ý¥«³õ¤W¤£@¤[µ¥ªº§ë¸ê¤H¤Ï¦Ó·|¶Ã¬åªÑ²¼¡A¥Ù¬Þªº«Ü |
|
|
|